<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride - Graudal, NA - 2020 | Cochrane Library</title> <meta content="Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride - Graudal, NA - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004022.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride - Graudal, NA - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004022.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD004022.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride" name="citation_title"/> <meta content="Niels Albert Graudal" name="citation_author"/> <meta content="Copenhagen University Hospital Rigshospitalet" name="citation_author_institution"/> <meta content="graudal@dadlnet.dk" name="citation_author_email"/> <meta content="ThorbjÃ¸rn Hubeck-Graudal" name="citation_author"/> <meta content="Aarhus University Hospital" name="citation_author_institution"/> <meta content="Gesche Jurgens" name="citation_author"/> <meta content="Roskilde Hospital" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD004022.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/12/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004022.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004022.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD004022.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Aldosterone [blood]; Asian People; Bias; Black People; Blood Pressure [*drug effects]; Catecholamines [blood]; Cholesterol [blood]; Confidence Intervals; *Diet, Sodium-Restricted; Epinephrine [blood]; Hypertension [*diet therapy, ethnology]; Norepinephrine [blood]; Randomized Controlled Trials as Topic; Recommended Dietary Allowances; Renin [blood]; Sodium Chloride, Dietary [*pharmacology]; Triglycerides [blood]; White People" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD004022.pub5&amp;doi=10.1002/14651858.CD004022.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="Xsb6SJyC";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD004022\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD004022\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ko","ms","fa","pl","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD004022.pub5",title:"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride",firstPublishedDate:"Dec 12, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Hypertension Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004022.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004022.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> EspaÃ±ol </option> <option class="content-language-option" data-languagecode="fa" value="fa"> ÙØ§Ø±Ø³Û </option> <option class="content-language-option" data-languagecode="fr" value="fr"> FranÃ§ais </option> <option class="content-language-option" data-languagecode="hi" value="hi"> à¤¹à¤¿à¤¨à¥à¤¦à¥ </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> æ¥æ¬èª </option> <option class="content-language-option" data-languagecode="ko" value="ko"> íêµ­ì´ </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> PortuguÃªs </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Ð ÑÑÑÐºÐ¸Ð¹ </option> <option class="content-language-option" data-languagecode="ro" value="ro"> RomÃ¢nÄ </option> <option class="content-language-option" data-languagecode="ta" value="ta"> à®¤à®®à®¿à®´à¯ </option> <option class="content-language-option" data-languagecode="th" value="th"> à¸ à¸²à¸©à¸²à¹à¸à¸¢ </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> ç¹é«ä¸­æ </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> ç®ä½ä¸­æ </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD004022.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD004022.pub5/full/es"> EspaÃ±ol </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004022.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD004022.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;ÚÚ©ÛØ¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì´ë¡&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en tÃ©rminos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Ø®ÙØ§ØµÙ Ø¨Ù Ø²Ø¨Ø§Ù Ø³Ø§Ø¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© simplifiÃ©&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;ì¬ì´ ë§ ìì½&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym jÄzykiem&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;æ·ºé¡¯ææçå£èªçµè«&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD004022.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD004022.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD004022.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD004022.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views:Â </span> <span>18187 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD004022.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0070"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0041"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-sec-0064"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/appendices#CD004022-sec-0075"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/supinfo/CD004022StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/supinfo/CD004022StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright Â© 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#CD004022-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Niels Albert Graudal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#CD004022-cr-0005">ThorbjÃ¸rn Hubeck-Graudal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information#CD004022-cr-0006">Gesche Jurgens</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information/en#CD004022-sec-0080">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 December 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD004022.pub5">https://doi.org/10.1002/14651858.CD004022.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD004022-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004022-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD004022-abs-0013">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004022-abs-0008">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004022-abs-0011">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004022-abs-0005">íêµ­ì´</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD004022-abs-0001" lang="en"> <section id="CD004022-sec-0001"> <h3 class="title" id="CD004022-sec-0001">Background</h3> <p>Recent cohort studies show that salt intake below 6 g is associated with increased mortality. These findings have not changed public recommendations to lower salt intake below 6 g, which are based on assumed blood pressure (BP) effects and no sideâeffects. </p> </section> <section id="CD004022-sec-0002"> <h3 class="title" id="CD004022-sec-0002">Objectives</h3> <p>To assess the effects of sodium reduction on BP, and on potential sideâeffects (hormones and lipids) </p> </section> <section id="CD004022-sec-0003"> <h3 class="title" id="CD004022-sec-0003">Search methods</h3> <p>The Cochrane Hypertension Information Specialist searched the following databases for randomized controlled trials up to April 2018 and a topâup search in March 2020: the Cochrane Hypertension Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (from 1946), Embase (from 1974), the World Health Organization International Clinical Trials Registry Platform, and ClinicalTrials.gov. We also contacted authors of relevant papers regarding further published and unpublished work. The searches had no language restrictions. The topâup search articles are recorded under "awaiting assessment." </p> </section> <section id="CD004022-sec-0004"> <h3 class="title" id="CD004022-sec-0004">Selection criteria</h3> <p>Studies randomizing persons to lowâsodium and highâsodium diets were included if they evaluated at least one of the outcome parameters (BP, renin, aldosterone, noradrenalin, adrenalin, cholesterol, highâdensity lipoprotein, lowâdensity lipoprotein and triglyceride,. </p> </section> <section id="CD004022-sec-0005"> <h3 class="title" id="CD004022-sec-0005">Data collection and analysis</h3> <p>Two review authors independently collected data, which were analysed with Review Manager 5.3. Certainty of evidence was assessed using GRADE. </p> </section> <section id="CD004022-sec-0006"> <h3 class="title" id="CD004022-sec-0006">Main results</h3> <p>Since the first review in 2003 the number of included references has increased from 96 to 195 (174 were in white participants). As a previous study found different BP outcomes in black and white study populations, we stratified the BP outcomes by race. </p> <p>The effect of sodium reduction (from 203 to 65 mmol/day) on BP in white participants was as follows: Normal blood pressure: SBP: mean difference (MD) â1.14 mmHg (95% confidence interval (CI): â1.65 to â0.63), 5982 participants, 95 trials; DBP: MD + 0.01 mmHg (95% CI: â0.37 to 0.39), 6276 participants, 96 trials. Hypertension: SBP: MD â5.71 mmHg (95% CI: â6.67 to â4.74), 3998 participants,88 trials; DBP: MD â2.87 mmHg (95% CI: â3.41 to â2.32), 4032 participants, 89 trials (all highâquality evidence). </p> <p>The largest bias contrast across studies was recorded for the detection bias element. A comparison of detection bias lowârisk studies versus high/unclear risk studies showed no differences. </p> <p>The effect of sodium reduction (from 195 to 66 mmol/day) on BP in black participants was as follows: Normal blood pressure: SBP: mean difference (MD) â4.02 mmHg (95% CI:â7.37 to â0.68); DBP: MD â2.01 mmHg (95% CI:â4.37, 0.35), 253 participants, 7 trials. Hypertension: SBP: MD â6.64 mmHg (95% CI:â9.00, â4.27); DBP: MD â2.91 mmHg (95% CI:â4.52, â1.30), 398 participants, 8 trials (lowâquality evidence).<br/>The effect of sodium reduction (from 217 to 103 mmol/day) on BP in Asian participants was as follows: Normal blood pressure: SBP: mean difference (MD) â1.50 mmHg (95% CI: â3.09, 0.10); DBP: MD â1.06 mmHg (95% CI:â2.53 to 0.41), 950 participants, 5 trials. Hypertension: SBP: MD â7.75 mmHg (95% CI:â11.44, â4.07); DBP: MD â2.68 mmHg (95% CI: â4.21 to â1.15), 254 participants, 8 trials (moderateâlowâquality evidence).<br/>Â  </p> <p>During sodium reduction renin increased 1.56 ng/mL/hour (95%CI:1.39, 1.73) in 2904 participants (82 trials); aldosterone increased 104 pg/mL (95%CI:88.4,119.7) in 2506 participants (66 trials); noradrenalin increased 62.3 pg/mL: (95%CI: 41.9, 82.8) in 878 participants (35 trials); adrenalin increased 7.55 pg/mL (95%CI: 0.85, 14.26) in 331 participants (15 trials); cholesterol increased 5.19 mg/dL (95%CI:2.1, 8.3) in 917 participants (27 trials); triglyceride increased 7.10 mg/dL (95%CI: 3.1,11.1) in 712 participants (20 trials); LDL tended to increase 2.46 mg/dl (95%CI: â1, 5.9) in 696 participants (18 trials); HDL was unchanged â0.3 mg/dl (95%CI: â1.66,1.05) in 738 participants (20 trials) (All highâquality evidence except the evidence for adrenalin). </p> </section> <section id="CD004022-sec-0007"> <h3 class="title" id="CD004022-sec-0007">Authors' conclusions</h3> <p>In white participants, sodium reduction in accordance with the public recommendations resulted in mean arterial pressure (MAP) decrease of about 0.4 mmHg in participants with normal blood pressure and a MAP decrease of about 4 mmHg in participants with hypertension. Weak evidence indicated that these effects may be a little greater in black and Asian participants. The effects of sodium reduction on potential side effects (hormones and lipids) were more consistent than the effect on BP, especially in people with normal BP. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD004022-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD004022-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD004022-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD004022-abs-0014">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD004022-abs-0009">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD004022-abs-0012">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/ko#CD004022-abs-0006">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="full/ms#CD004022-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD004022-abs-0010">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD004022-abs-0004">ç¹é«ä¸­æ</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD004022-abs-0002" lang="en"> <h3>The effect of a low salt diet on blood pressure and some hormones and lipids in people with normal and elevated blood pressure </h3> <p><b>Review question</b> </p> <p>In this 4th Cochrane update since 2003, studies in which participants were distributed by chance into groups with high and low salt intake were analysed to investigate the effect of reduced salt intake on blood pressure (BP) and potential side effects of salt reduction on some hormones and lipids. </p> <p><b>Background</b> </p> <p>As a reduction in salt intake decreases blood pressure (BP) in individuals with elevated BP, we are commonly advised to cut down on salt, assuming that this will reduce mortality. However, the effect of salt reduction on BP in people with normal BP has been questioned. Furthermore, several studies have shown that salt reduction activates the salt conserving hormonal system (renin and aldosterone), the stress hormones (adrenalin and noradrenalin) and increases fatty substances (cholesterol and triglyceride) in the blood. Finally, recent observations in general populations indicate that a low salt intake is associated with increased mortality </p> <p><b>Search date</b> </p> <p>The present evidence is current to April 2018.</p> <p><b>Study characteristics</b> </p> <p>One hundred and ninetyâfive intervention studies of 12296 individuals lasting three to 1100 days were included, which evaluated at least one of the effect measures. Participants were healthy or had elevated blood pressure. Longitudinal studies have shown that the effect of reduced salt intake on BP is stable after at maximum seven days and population studies have shown that very few people eat more than 14.5 g salt per day. Therefore, we also performed subgroup analyses of 131 studies with a duration of at least seven days and a salt intake of maximum 14.5 g. </p> <p><b>Study funding sources</b> </p> <p>Only six studies were supported by food industry organisations.</p> <p><b>Key results</b> </p> <p>The mean salt intake was reduced from 11.5 g per day to 3.8 g per day. The reduction in SBP/DBP in people with normal blood pressure was 1.1/0 mmHg (about 0.3%) , and in people with hypertension 5.7/2.9 mmHg (about 3%). In contrast, the effect on hormones and lipids were similar in people with normotension and hypertension. Renin increased 55%; aldosterone increased 127%; adrenalin increased 14%; noradrenalin increased 27%; cholesterol increased 2.9%; and triglyceride increased 6.3%. </p> <p><b>Quality of evidence</b> </p> <p>Only randomised controlled trials were included and the grade of evidence was therefore considered to be high, although downgraded in some of the smaller analyses. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD004022-sec-0070" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD004022-sec-0070"></div> <h3 class="title" id="CD004022-sec-0071">Implications for practice</h3> <section id="CD004022-sec-0071"> <p>The present metaâanalysis shows that a lowâ versus highâsodium diet in white people with normal blood pressure (BP) decreases BP less than 1%. A significant concomitant increase in plasma renin, plasma aldosterone, plasma noradrenalin, and to a lesser degree of plasma adrenaline may contribute to the small effect of sodium reduction on BP. Furthermore, sodium reduction resulted in a significant increase in plasma cholesterol and plasma triglyceride, which expressed in percentage, was numerically larger than the decrease in BP. Due to the relatively small effects and due to the antagonistic nature of the effects (decrease in BP, increase in hormones and lipids), these results do not support that sodium reduction may have net beneficial effects in a population ofÂ  white people with normal BP. </p> <p>In white people with elevated BP, sodium reduction decreases BP by about 3.5%, indicating that sodium reduction may be used as a supplementary treatment for hypertension. In Asian and black people the effect of sodium reduction was a little larger than in white people, but at present too few studies have been carried out to conclude differently from that above. </p> </section> <h3 class="title" id="CD004022-sec-0072">Implications for research</h3> <section id="CD004022-sec-0072"> <p>The data suggesting that black and Asian populations are more sensitive to sodium reduction than white people requires further studies. In future studies of mixed populations, it is important that the effects on white, black and Asian populations are reported separately. Population studies have shown a Uâshaped association between sodium intake and mortality indicating that the beneficial effect of sodium reduction on BP outweigh the harmful effect on hormones and lipids at sodium intake above the usual sodium intake, but that the harms of sodium reduction outweigh the benefits at sodium intake below the usual sodium intake. Longâterm randomised controlled trials (RCTs) with mortality and morbidity outcomes would be desirable to confirm or reject these findings. However, such studies may not be practicable. After 195 RCTs and 27 population studies without an obvious signal in favour of sodium reduction below 100 mmol/day, another position could be to accept that the present usual sodium intake may be the optimal intake for the general population. As suggested by the National Academy of MedicineÂ the primary need may be to revise the process of the establishment of the dietary guidelines. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD004022-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD004022-sec-0008"></div> <div class="table" id="CD004022-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in white participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> White population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in Europe and North America </p> <p><b>Duration: Shortest duration 3 days in main analysis and 7 days in subgroupâanalysis.</b> </p> <p><b>Intervention:</b> Low sodium intake (Main analysis: Mean 64 mmol/24h. Subgroup analysis: Mean 65 mmol/24h) ) </p> <p><b>Comparison:</b> High sodium intake (Main analysis: Mean 204 mmol/24h. Subgroup analysis: Mean 192 mmol/24h)) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean Difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.14 [â1.65 to â0.63]</p> <p><i>â1.38 [â1.87, â0.89]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5982<br/>(95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.01 [â0.37 to 0.39]</p> <p><i>â0.37 [â0.78, 0.04]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6276<br/>(96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â5.71 [â6.67 to â4.74]</p> <p><i>â5.32 [â6.36, â4.28]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3998<br/>(88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.87 [â3.41 to â2.32]</p> <p><i>â2.76 [â3.38, â2.13]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4032<br/>(89) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>* Outcome of studies with duration of at least 7 days and high sodium intake of maximum 250 mmol </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004022-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in black participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Black population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in North America, UK and Africa </p> <p><b>Duration: Shortest duration 5 days .</b> </p> <p><b>Intervention:</b> Low sodium intake (Mean 66 mmol/24 h) </p> <p><b>Comparison:</b> High sodium intake (Mean 195 mmol/24h) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â4.02 (â7.37 to â0.68)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.01 (â4.37 to 0.35)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b><sup>low1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â6.64 (â9.00 to â4.27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.91 (â4.52 to â1.30)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>1. Downgraded due to the wide confidence intervals, inconsistent outcomes and few studies </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004022-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in Asian participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Asian population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in Japan and China </p> <p><b>Duration: Shortest duration 6 days.</b> </p> <p><b>Intervention:</b> Low sodium intake (Mean 103 mmol/24h) </p> <p><b>Comparison:</b> High sodium intake (Mean 217 mmol/24h) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.50 [â3.09, 0.10]</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.06 [â2.53, 0.41]</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â7.75(â11.44 to â4.07)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.68 (â4.21 to â1.15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>1. Downgraded due to few studies</p> <p>2. Downgraded due to wide confidence intervals, inconsistent outcomes and few studies</p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004022-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for hormones</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Low sodium intake compared with high sodium intake for hormones</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units </p> <p><b>Intervention:</b> Low sodium intake </p> <p><b>Comparison:</b> High sodium intake </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renin</b> </p> <p>ng/ml/hour</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.56 [1.39 to 1.73]</p> <p><i><sub>N*: 1.83 [1.56 to 2.10]</sub> </i> </p> <p><i><sub>H*: 1.26 [1.04 to 1.49]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2904<br/>(91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Aldosterone</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102.4 [86.9 to 117.8]</p> <p><i><sub>N*: 123.8 [99.5 to 148.1</sub> </i><sub>]</sub> </p> <p><i><sub>H*: 67.4 [53.5 to 81.3]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2506<br/>(70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Noradrenaline</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62.3 [41.9 to 82.8]</p> <p><i><sub>N*: 61.5 [40.4 to 82.6]</sub> </i> </p> <p><i><sub>H*: 54.0 [1.8 to 106.2]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>878<br/>(38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adrenaline</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7.55 [0.85 to 14.26]</p> <p><i><sub>N*:9.1 [-1.2 to 19.4]</sub> </i> </p> <p><i><sub>H*:4.21 [-2.7 to 11.11]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331<br/>(16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>SMD:</b> standardised mean difference </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>N*: Study populations with mean SBP &lt; 140 mmHg and mean DBP &lt; 90 mmHg</p> <p>H*:Study populations with mean SBP &gt; 140 mmHg and/or mean DBP &gt; 90 mmHg</p> <p>1. Downgraded due to the wide confidence interval and few studies</p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD004022-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for lipids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units </p> <p><b>Intervention:</b> Low sodium intake </p> <p><b>Comparison:</b> High sodium intake </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cholesterol</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5.19 [2.1 to 8.3]</p> <p><i><sub>N*:5.98 (2.0 to 10.0)</sub> </i> </p> <p><i><sub>H*:3.95 (-1.1, 9.0)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>917<br/>(28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trigyceride</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7.10 [3.1 to 11.1]</p> <p><i><sub>N*: 7.1 (2.9 to 11.4)</sub> </i> </p> <p><i><sub>H*: 7 (-3.7 to 17.8)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>712<br/>(20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Highâdensity lipoprotein (HDL)</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â0.3 [â1.66, 1.05]</p> <p><i><sub>N*: 0 (-1.6 to 1.6)</sub> </i> </p> <p><i><sub>H*: -1 (-3.4 to 1.4)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>738<br/>(20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ</p> <p><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lowâdensity lipoprotein (LDL)</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.46 [â1.0 to 5.9]</p> <p><i><sub>N*: 2.6 (-1.5 to 6.7)</sub> </i> </p> <p><i><sub>H*: 2.2 (-4.0 to 8.4)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>696<br/>(18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD004022-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD004022-sec-0009"></div> <section id="CD004022-sec-0010"> <h3 class="title" id="CD004022-sec-0010">Description of the condition</h3> <p>Sodium is essential for life. Man can survive on a very low sodium diet of about 7â8 mmol/d as exemplified by the Yanamamo Indians in the Brazilian jungle (<a href="./references#CD004022-bbs2-0304" title="OliverJW , CohenEL , NeelJV . Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a âno-saltâ culture. Circulation1975;52:146-51.">Oliver 1975</a>), but also has a very large capacity to eat sodium of about 0,4 g/kg bodyweight, i.e. about 30 g/d (1500 mmol/d). It is not precisely defined, which sodium intake is the optimal for the general health, but the present usual sodium intake (100â200 mmol/d) is in the low end of this tolerable interval (7â1500 mmol) . </p> <p>Some health institutions (<a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a>), and dietary recommendations (<a href="./references#CD004022-bbs2-0260" title="US Department of Health and Human Services, US Department of Agriculture. 2015-2020 DietaryGuidelines for Americans. 8th ed.Washington, DC: http://www.health.gov/DietaryGuidelines. Accessed December 16, 20152015.">DGA 2015</a>), assume that reduction in sodium intake from "high" to "low" levels is associated with reduction in systolic and diastolic blood pressure (SBP and DBP), which might result in a decrease in mortality. However, the definitions of âhighâ, ânormalâ and âlowâ sodium intake are unclear. The present usual sodium intake indicates that an intake in the interval 109 mmol/day to 209 mmol/day (<a href="./references#CD004022-bbs2-0297" title="McCarronDA , KazaksAG , GeerlingJC , SternJS , GraudalNA . Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide. American Journal of Hypertension2013;26:1218-23.">McCarron 2013</a>; <a href="./references#CD004022-bbs2-0307" title="PowlesJ , FahimiS , MichaR , KhatibzadehS , ShiP , EzzatiM , et al. Global, regional and national sodium intakesin 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open2013;3:e003733.">Powles 2013</a>, <a href="#CD004022-tbl-0006">Table 1</a>) would be ânormalâ, a high sodium intake would be above 209 mmol/day and a low sodium intake would be below 109 mmol/day, but according to the health institutions a ânormalâ sodium intake is below 100 mmol/day (<a href="./references#CD004022-bbs2-0260" title="US Department of Health and Human Services, US Department of Agriculture. 2015-2020 DietaryGuidelines for Americans. 8th ed.Washington, DC: http://www.health.gov/DietaryGuidelines. Accessed December 16, 20152015.">DGA 2015</a>), or below 87 mmol/day (<a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a>), and a sodium intake above 100 mmol/day is âhighâ, whereas a âlowâ sodium intake is not defined. The confusion is strengthened by the use of different terms to describe salt (salt (sodium chloride) and sodium) and different units for salt/sodium intake (mg/day or mmol/day). To reduce the confusion we have shown the different definitions and units for salt and sodium intake in <a href="#CD004022-tbl-0006">Table 1</a>. In the present review, which represents a fourth update of the first metaâanalysis that includes an analysis of hormones and lipids in addition to blood pressure (<a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a>), updated in 2003 (<a href="./references#CD004022-bbs2-0325" title="JÃ¼rgensG , GraudalNA . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database of Systematic Reviews2003, Issue 1. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub2]">JÃ¼rgens 2003</a>),2011 (<a href="./references#CD004022-bbs2-0323" title="GraudalN , Hubeck-GraudalT , JÃ¼rgensG . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2011, Issue 11. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub3]">Graudal 2011</a>), and 2017 (<a href="./references#CD004022-bbs2-0324" title="GraudalN , Hubeck-GraudalT , JÃ¼rgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2017, Issue 4. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub4]">Graudal 2017</a>), we use the term "sodium" and the unit "mmol". </p> <div class="table" id="CD004022-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Sodium intake in populations</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Recommended</p> <p>upper level*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, lower</p> <p>range*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, lower</p> <p>2.5%*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World,</p> <p>mean*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, Upper</p> <p>97.5%*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, upper</p> <p>range*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0260" title="US Department of Health and Human Services, US Department of Agriculture. 2015-2020 DietaryGuidelines for Americans. 8th ed.Washington, DC: http://www.health.gov/DietaryGuidelines. Accessed December 16, 20152015.">DGA 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>1</sup> (2300)<sup>2</sup> </p> <p>(5800)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87<sup>1</sup> (2000)<sup>2</sup> </p> <p>(5046)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0297" title="McCarronDA , KazaksAG , GeerlingJC , SternJS , GraudalNA . Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide. American Journal of Hypertension2013;26:1218-23.">McCarron 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90<sup>1</sup> (2070)<sup>2</sup> </p> <p>(5220)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109<sup>1</sup> (2500)<sup>2</sup> </p> <p>(6320)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159<sup>1</sup> (3660)<sup>2</sup> </p> <p>(9220)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>209<sup>1</sup> (4810)<sup>2</sup> </p> <p>(12120)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248<sup>1</sup> (5700)<sup>2</sup> </p> <p>(14400)<sup>3</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0307" title="PowlesJ , FahimiS , MichaR , KhatibzadehS , ShiP , EzzatiM , et al. Global, regional and national sodium intakesin 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open2013;3:e003733.">Powles 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95<sup>1</sup> (2200)<sup>2</sup> </p> <p>(5510)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172<sup>1</sup> (3950)<sup>2</sup> </p> <p>(10000)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240<sup>1</sup> (5520)<sup>2</sup> </p> <p>(13920)<sup>3</sup> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>1mmol; 2mg sodium; 3 mg sodium chloride</p> </div> </div> <p>Blood pressure is associated with mortality (<a href="./references#CD004022-bbs2-0255" title="CollinsR , PetoR , MacMahonS , HebertP , FiebachNH , EberleinKA , GodwinJ , et al. Blood pressure, stroke and coronary heart disease. Part 2, short term reductions in blood pressure; overview of randomised drug trials in their epidemiological context. Lancet1990;335(8693):827-38.">Collins 1990</a>).The hypothesis that a reduced sodium intake (sodium reduction) will reduce blood pressure (BP) and subsequently reduce morbidity and mortality was raised in 1904 on the basis of individual patient cases (<a href="./references#CD004022-bbs2-0246" title="AmbardL , BeaujardE . Causes of arterial hypertension [Causes de l'hypertension artÃ©rielle]. Archives of General Medicine1904;81:520â33.">Ambard 1904</a>). Subsequently in 1907, these results were opposed (<a href="./references#CD004022-bbs2-0296" title="LÃ¶wensteinC . No English title [Ãber Beziehungen zwischen Kochsalzhaushalt und Blutdruck bei Nierenkranken]. Archiv fÃ¼r Experimentelle Pathologie und Pharmakologie1907;57(1):137â61.">LÃ¶wenstein 1907</a>). The clinical and physiological effects of salt published in studies during the first half of the 20th century were reviewed in 1949 (<a href="./references#CD004022-bbs2-0250" title="ChapmannCP , GibbonsTB . The diet and hypertension. A review. Medicine1949;29:29-69.">Chapman 1949</a>). Consequently, scientific studies have been performed for almost 70 years before modern standard scientific randomised controlled trials (RCTs) (<a href="./references#CD004022-bbs2-0001" title="ParijsJ , JoossensJV , Van der LindenL , VerstrekenG , AmeryAKPC . Moderate sodium restriction and diuretics in the treatment of hypertension. American Heart Journal1973;85:22-34. ">1000 Parijs 1973 (H)</a>) and observational studies (<a href="./references#CD004022-bbs2-0294" title="KaganA , PopperJS , RhoadsGG , YanoK . Dietary and other risk factorsfor stroke in Hawaiian Japanese men. Stroke1985;16:390-6.">Kagan 1985</a>) were performed in humans. Despite the nonâexistence of RCTs and population studies, sodiumâreduction for hypertension was introduced as a national priority in USA in 1969 (<a href="./references#CD004022-bbs2-0317" title="Officers and staff, White House Conference on Food, Nutrition, and Health. White House Conferenceon Food, Nutrition and Health. FINAL REPORT. Washington DC: U.S. Government Printing Office, 1970. [https://babel.hathitrust.org/cgi/pt?id=umn.31951d02987449r;view=1up;seq=4]">White House conference 1969â70</a>) and for the general population in 1977 (<a href="./references#CD004022-bbs2-0261" title="Staff of the Select Committee on Nutrition and Human Needs, United States Senate. Dietary goals for the United States. Washington DC: U.S. Government printing office, 1977. [https://thescienceofnutrition.files.wordpress.com/2014/03/dietary-goals-for-the-united-states.pdf]">Dietary Goals US 1977</a>). The subsequent RCTs and observational studies have been interpreted differently (<a href="./references#CD004022-bbs2-0310" title="TaubesG . The (political) science of salt. Science1998;281:898-907.">Taubes 1998</a>, <a href="./references#CD004022-bbs2-0274" title="GraudalN . Commentary: Possible role of salt intake in the development of essential hypertension. International Journal of Epidemiology2005;34(5):972-4.">Graudal 2005</a>, <a href="./references#CD004022-bbs2-0247" title="BayerR , JohnsDM , GaleaS . Salt and public health: contested science and the challenge of evidence-based decision making. Health Affairs2012;31(12):2738-46.">Bayer 2012</a>). While health institutions (<a href="./references#CD004022-bbs2-0289" title="Institute of Medicine. Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate. Washington DC: National Academies Press, 2005.">IOM 2005</a>, <a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a>, <a href="./references#CD004022-bbs2-0260" title="US Department of Health and Human Services, US Department of Agriculture. 2015-2020 DietaryGuidelines for Americans. 8th ed.Washington, DC: http://www.health.gov/DietaryGuidelines. Accessed December 16, 20152015.">DGA 2015</a>) support sodium reduction below 100 mmol/day, sceptics have claimed that this recommended upper limit (UL) for sodium intake is based on a biased selection of evidence (<a href="./references#CD004022-bbs2-0264" title="FolkowB . On bias in medical research; reflections on present salt-cholesterol controversies. Scandinavian Cardiovascular Journal2011;45(4):194-7.">Folkow 2011</a>, <a href="./references#CD004022-bbs2-0278" title="GraudalN, JÃ¼rgensG . Conflicting Evidence on Health Effects Associated with Salt Reduction Calls for a Redesign of the Salt Dietary Guidelines.. Prog Cardiovasc Dis2018;61:20-26.">Graudal and JÃ¼rgens 2018</a>), and is inconsistent with Institute of Medicineâs definition of an adequate nutrient intake, which is âthe approximate intake found in apparently healthy populations" (<a href="./references#CD004022-bbs2-0290" title="Institute of Medicine. Dietary Reference Intakes: Essential Guide to Nutrient Requirements. Washington DC: National Academies Press, 2006.">IOM 2006</a>; <a href="./references#CD004022-bbs2-0284" title="HeaneyRP . Sodium: how and how not to set a nutrient intake recommendation. American Journal of Hypertension2013;26:1194-7.">Heaney 2013</a>). For sodium "the approximate intake in apparently healthy populations" is between 90 mmol/day and 248 mmol/day (<a href="#CD004022-tbl-0006">Table 1</a>). </p> <p>The present 4th updated Cochrane review is based on a metaâanalysis published in 1998 (<a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a>). In 1998, the usual sodium intake was known in some populations, but it was not wellâdefined worldwide until recently (<a href="#CD004022-tbl-0006">Table 1</a>). Furthermore, the significance of the duration of sodium reduction was not established. In 1998, we therefore included all available randomised studies, irrespective of sodium intake and duration of intervention, assuming that the average values of multiple studies would be relevant for the general population. We separated study populations in a group of populations with normal BP to investigate the potential effect of sodium reduction in the general population and in a group of hypertensive populations to investigate the potential effect of sodium reduction as a treatment for hypertensive individuals. In a crossâsectional multiple regression analysis including many coâvariates we found that the duration of the sodium reduction intervention had no impact on the effect of sodium reduction on BP (<a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a>). In addition to this crossâsectional metaâregression analysis, a recent metaâanalysis of longitudinal studies measuring the BPâeffect of sodium reduction several times during the observation period showed that there was no difference in SBP effect or DBP effect between week one and week six, thus estimating the time point for maximal efficacy to be one week (<a href="./references#CD004022-bbs2-0276" title="GraudalNA , Hubeck-GraudalT , JurgensG , McCarronDA . The significance of duration and dose of sodium reduction intervention in normotensive and hypertensive individuals. A meta-analysis. Advances in Nutrition2015;6(2):169-77.">Graudal 2015</a>). These results are shown in <a href="#CD004022-tbl-0007">Table 2</a>. In the <a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a> analysis, the average sodium intake in the nonâreduced group was 203 mmol/day and in the reduced group it was 62 mmol/day. In the two following updates of the review, the corresponding sodium reductions were from 205 mmol/day to 64 mmol/day (<a href="./references#CD004022-bbs2-0325" title="JÃ¼rgensG , GraudalNA . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database of Systematic Reviews2003, Issue 1. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub2]">JÃ¼rgens 2003</a>) and from 202 mmol/day to 67 mmol/day (<a href="./references#CD004022-bbs2-0323" title="GraudalN , Hubeck-GraudalT , JÃ¼rgensG . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2011, Issue 11. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub3]">Graudal 2011</a>). We now know (<a href="./references#CD004022-bbs2-0297" title="McCarronDA , KazaksAG , GeerlingJC , SternJS , GraudalNA . Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide. American Journal of Hypertension2013;26:1218-23.">McCarron 2013</a>; <a href="./references#CD004022-bbs2-0307" title="PowlesJ , FahimiS , MichaR , KhatibzadehS , ShiP , EzzatiM , et al. Global, regional and national sodium intakesin 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open2013;3:e003733.">Powles 2013</a>) that this reduction corresponds to a reduction from a high usual level to the present recommended levels below 100 mmol (<a href="./references#CD004022-bbs2-0289" title="Institute of Medicine. Dietary Reference Intakes: Water, Potassium, Sodium, Chloride, and Sulfate. Washington DC: National Academies Press, 2005.">IOM 2005</a>) (<a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a>) i.e. the present review is relevant in the context of evaluating the consequences of the present recommendations to reduce sodium intake to a level below 100 mmol/day. </p> <div class="table" id="CD004022-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Differences in BP effects of reduced sodium intake at different time points in longitudinal studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>References</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SBP diff. (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DBP diff. (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 1 vs.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1070 Parker 1990 (H);1180 Palacios 2004 B;1183 Gates 2004 (H);1188 Swift 2005 (H)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.18 (â3.03 to 2.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (â2.53 to 2.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 1 vs.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0064" title="ParkerM , PuddeyIB , BeilinLJ , VandongenR . Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension1990;16:398-406. ">1070 Parker 1990 (H)</a>;<a href="./references#CD004022-bbs2-0079" title="RuppertM , OverlackA , KollochR , KraftK , GÃ¶belB , StumpeKO . Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. Hypertension1993;11:743-9. ">1088 Ruppert 1993</a>;<a href="./references#CD004022-bbs2-0109" title="SchorrU , DistlerA , SharmaAM . Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial. Journal of Hypertension1996;14:131-5. ">1128 Schorr 1996</a>;<a href="./references#CD004022-bbs2-0159" title="PalaciosC , WigertzK , MartinBR , JackmanL , PrattJH , PeacockM , et al. Sodium retention in black and white female adolescents in response to salt intake. Journal of Clinical Endocrinology &amp; Metabolism2004;89:1858-63. ">1180 Palacios 2004</a>;<a href="./references#CD004022-bbs2-0162" title="GatesPE , TanakaH , HiattWR , SealsDR . Dietary sodium restriction rapidly improves large elastic artery compliance inolder adults with systolic hypertension. Hypertension2004;44:35-41. ">1183 Gates 2004 (H)</a>;<a href="./references#CD004022-bbs2-0165" title="ForresterT , AdeyemoA , Soarres-WynterS , SargentL , BennettF , WilksR , et al. A randomized trial on sodium reduction in two developing countries. Journal of Human Hypertension2005;19:55-60. ">1186 Forrester 2005 N</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.50 (â3.20 to 2.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (â2.02 to 2.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 2 vs.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0011" title="MacGregorGA , MarkanduND , BestFE , ElderDM , CamJM , SagnellaGA , et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet1982;1(8268):351-5. ">1011 MacGregor 1982 (H)</a>;<a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0064" title="ParkerM , PuddeyIB , BeilinLJ , VandongenR . Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension1990;16:398-406. ">1070 Parker 1990 (H)</a>;<a href="./references#CD004022-bbs2-0068" title="MascioliS , Grimm R Jr, LaunerC , et al. Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure. Hypertension1991;17(Suppl 1):I21-6. ">1075 Mascioli 1991</a>;<a href="./references#CD004022-bbs2-0076" title="CobiacL , NestelPJ , WingLMH , HowePRC . A low sodium diet supplemented with fish oil lowers blood pressure in the elderly. Journal of Hypertension1992;10:87-92. ">1082 Cobiac 1992</a> </p> <p><a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0086" title="FotherbyMD , PotterJF . Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects. Journal of Hypertension1993;11:657-63. ">1100 Fotherby 1993 (H)</a>;<a href="./references#CD004022-bbs2-0074" title="HugginsRL , Di NicolantonioR , Morgan, TO. Preferred salt levels and salt taste acuity in human subjects after ingestion of untasted salt. Appetite1992;18:111-9. ">1080 Huggins 1992</a>;<a href="./references#CD004022-bbs2-0162" title="GatesPE , TanakaH , HiattWR , SealsDR . Dietary sodium restriction rapidly improves large elastic artery compliance inolder adults with systolic hypertension. Hypertension2004;44:35-41. ">1183 Gates 2004 (H)</a>;<a href="./references#CD004022-bbs2-0165" title="ForresterT , AdeyemoA , Soarres-WynterS , SargentL , BennettF , WilksR , et al. A randomized trial on sodium reduction in two developing countries. Journal of Human Hypertension2005;19:55-60. ">1186 Forrester 2005 N</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.10 (â1.88 to 1.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.20 (â1.12 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 2 vs.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0078" title="SciarroneSEG , BeilinLJ , RouseIL , RogersPB . A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. Journal of Hypertension1992;10:287-98. ">1085 Sciarrone 1992 (H)</a>;<a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.50 (â2.66 to 1.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.42 (â1.69 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 4 vs.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0078" title="SciarroneSEG , BeilinLJ , RouseIL , RogersPB . A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. Journal of Hypertension1992;10:287-98. ">1085 Sciarrone 1992 (H)</a>;<a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.39 (â1.77 to 2.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.22 (â1.50 to 1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Data from <a href="./references#CD004022-bbs2-0276" title="GraudalNA , Hubeck-GraudalT , JurgensG , McCarronDA . The significance of duration and dose of sodium reduction intervention in normotensive and hypertensive individuals. A meta-analysis. Advances in Nutrition2015;6(2):169-77.">Graudal 2015</a> </p> </div> </div> </section> <section id="CD004022-sec-0011"> <h3 class="title" id="CD004022-sec-0011">Description of the intervention</h3> <p>As in the previous metaâanalyses, RCTs are included, which allocate participants to two diets with a different content of salt (sodium chloride) or to either salt tablets or placebo tablets. The compliance in the RCTs is ensured by measurement of sodium excretion in the urine, which is accepted to be a reliable surrogate for the measuring of sodium intake. The sodium content of the âhighâ and âlowâ sodium diets were not defined according to the recommendations or the usual sodium intake, but just to describe the relative content of the two randomised study populations. </p> </section> <section id="CD004022-sec-0012"> <h3 class="title" id="CD004022-sec-0012">How the intervention might work</h3> <p>Extracellular fluid volume (ECFV) is determined by the balance between sodium intake and renal excretion of sodium. A steady state exists whereby sodium intake equals output, while ECFV is expanded during salt loads and shrunken during salt restriction (<a href="./references#CD004022-bbs2-0305" title="PalmerBF , AlpernRJ , SeldinDW . Physiology and pathophysiology of sodium retention and wastage. In: AlpernRJ , HebertSC , editors(s). Seldin and Giebisch's The Kidney. 4th edition. Amsterdam: Elsevier, Academic Press, 2008:1005-49.">Palmer 2008</a>). Thus, the idea behind sodium reduction is to shrink ECFV in order to decrease BP. The precondition for this idea is that the smaller ECFV associated with the decrease in BP has no counteracting effects on health outcomes that could outweigh the BPâeffect. </p> </section> <section id="CD004022-sec-0013"> <h3 class="title" id="CD004022-sec-0013">Why it is important to do this review</h3> <p>A verification of the hypothetical sodiumâBP relationship would support continuous attempts to lower sodium intake in order to reduce mortality. In this context it is important to define the correct UL for a healthy sodium intake, which would have a significant impact on the strategy to lower sodium intake. For instance if 100 mmol/day is the correct UL, more than 95% of the Worldâs populations should reduce sodium intake, but if the UL is 250 mmol/day, only about 5% should reduce sodium intake. In the latter case, a strategy to lower sodium intake in the general population would not be necessary, which would save significant efforts and costs. The same would be the case if the sodiumâBP relationship could be denied, as indicated by many RCTs of participants with normal BP (Graudal 2017). Worst case scenario is that sodium reduction could lead to side effects, which might trump the potential BP effect and result in increased mortality, as indicated by longitudinal observational studies (Alderman 2010, Pfister 2014, O'Donnell 2014, Graudal 2014; Mente 2016). Consequently, it is important to investigate the effect of sodium reduction not only on BP, but also on potential surrogate markers for clinical side effects. In our first metaâanalysis (Graudal 1998) different races were mixed. Due to the clinical observation in the DASH study (DASH 2001) that black participantsÂ had a greater response to sodium reduction than white participants, we decided to examine this possibility. Accordingly, we stratified blood pressure outcomes by race in the first Cochrane version, and because this stratification indicated racial differences, (JÃ¼rgens 2003), we have maintained this stratification of blood pressure outcomes in white, black and Asian populations in later versions including the present one. The first Cochrane version was invited by Cochrane and based on the 1998 version. Therefore there is no protocol. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD004022-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD004022-sec-0014"></div> <p>The purpose of the present review was to estimate the influence of lowâ versus highâdietary sodium intake on systolic blood pressure (SBP) and diastolic blood pressure (DBP), and blood concentrations of renin, aldosterone, catecholamines, cholesterol, highâdensity lipoprotein (HDL), lowâdensity lipoprotein (LDL) and triglyceride to contribute to the evaluation of the possible suitability of sodium reduction as a prophylaxis initiative and treatment of hypertension. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD004022-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD004022-sec-0015"></div> <section id="CD004022-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD004022-sec-0017"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs), doubleâblind or open, parallel or crossâover, allocating participants to diets with different sodium contents, the lowest defined as âlowâ and the highest defined as âhighâ, and in which the sodium intake was estimated by the 24âhour urinary sodium excretion (either measured on the basis of a 24âhour urine collection, or estimated from a sample of at least eight hours). </p> </section> <section id="CD004022-sec-0018"> <h4 class="title">Types of participants</h4> <p>Study populations were included irrespective of sex and age and stratified by race (black/white/Asian populations) and blood pressure (normotension/hypertension). If race was not defined, the study population was defined according to the predominant race in the study country. If data were not reported separately by race in mixed populations, the mixed population was classified according to the predominant race in the study. Hypertension was defined as SBP â¥ 140 mmHg and/or DBP â¥ 90 mmHg. Study populations in which participants were treated with antihypertensive treatment were defined as hypertensive irrespective of baseline BP. Studies systematically investigating participants with comorbidities, for instance diabetes or heart failure, were excluded. Studies, which tested for sodium sensitivity and excluded participants, who were either sodium sensitive or sodium resistant, were also excluded. </p> </section> <section id="CD004022-sec-0019"> <h4 class="title">Types of interventions</h4> <p>The intervention was a change in sodium intake, the study populations randomly being divided into a group eating a âlowâ sodium diet or a "high" sodium diet. As "low" and "high" were not specifically defined in relation to the usual intake or the definitions of the health institutions (<a href="http://Table 1" target="_blank">Table 1</a>), both diets could contain any amount of sodium, the assumption being that in most studies a "low" sodium diet would contain sodium within the low range (&lt; 100 mmol)/day or usual range (100 mmol to 250 mmol/day) and the âhighâ sodium diet would contain sodium within the usual range (100 mmol to 250 mmol/day) or above the usual range (â¥ 250 mmol/day). Confounding was not allowed, i.e. studies treating persons with a concomitant intervention such as an antihypertensive medication, potassium supplementation or weight reduction were only included if the concomitant intervention was identical during the low and the highâsodium diet. </p> </section> <section id="CD004022-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>All outcomes were considered primary outcomes.Â </p> <section id="CD004022-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>Outcome measures were effects on SBP, DBP, renin, aldosterone, adrenaline, noradrenaline, triglyceride, cholesterol, LDL and HDL. In studies reporting BP only as mean arterial pressure (MAP), SBP was estimated from SBP = 1.3 MAP + 1.4, and DBP was estimated from DBP = 0.83 MAP â 0.7 (<a href="./references#CD004022-bbs2-0313" title="TozawaM , IsekiK , IsekiC , OshiroS , YamazatoM , HigashiuesatoY , et al. Evidence for elevated pulse pressure in patients on chronic hemodialysis: acase-control study. Kidney International2002;62:2195-201.">Tozawa 2002</a>). Separate metaâanalyses were performed for each outcome measure. Concerning blood pressure, outcomes were stratified by race (white, black and AsianÂ populations) and according to level of blood pressure (hypertension or normotension). All other outcome variables were stratified according to level of BP (normotension/hypertension) but not by race. A minimum duration of intervention before time of measurement was not defined, but additional analyses were performed on studies with a duration of at least 7 days. </p> </section> <section id="CD004022-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p>None.</p> </section> </section> </section> <section id="CD004022-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD004022-sec-0024"> <h4 class="title">Electronic searches</h4> <p>The Cochrane Hypertension Information Specialist conducted systematic searches in the following databases for randomised controlled trials without language, publication year or publication status restrictions: </p> <p> <ul id="CD004022-list-0001"> <li> <p>the Cochrane Hypertension Specialised Register via the Cochrane Register of Studies (CRSâWeb) (searched 11 April 2018); </p> </li> <li> <p>the Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 3, 2018)Â via the Cochrane Register of Studies (CRSâWeb) (searched 11 April 2018); </p> </li> <li> <p>MEDLINE Ovid, MEDLINE Ovid Epub Ahead of Print, and MEDLINE Ovid InâProcess &amp; Other NonâIndexed Citations (searched 11 April 2018); </p> </li> <li> <p>Embase Ovid (searched 11 April 2018);</p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) searched 11 April 2018); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>) searched 11 April 2018). </p> </li> </ul> </p> <p>The Hypertension Group Specialised Register includes controlled trials from searches of CAB Abstracts &amp; Global Health, CINAHL, Cochrane Central Register of Controlled Trials, Embase, MEDLINE, ProQuest Dissertations &amp; Theses, PsycINFO, and Web of Science. </p> <p>The Information Specialist modelled subject strategies for databases on the search strategy designed for MEDLINE. Where appropriate, they were combined with subject strategy adaptations of the sensitivity and precisionâmaximising search strategy designed by Cochrane for identifying randomised controlled (as described in the Cochrane Handbook for Systematic Reviews of Interventions Version 6 (Handbook 2019)). We present search strategies for major databasesÂ in <a href="./appendices#CD004022-sec-0076">Appendix 1</a>. </p> </section> <section id="CD004022-sec-0025"> <h4 class="title">Searching other resources</h4> <p> <ul id="CD004022-list-0002"> <li> <p>The Cochrane Hypertension Information Specialist searched the Hypertension Specialised Register segment (which includes searches of MEDLINE, Embase and Epistemonikos for systematic reviews) to retrieve existing systematic reviews relevant to this systematic review, so that we could scan their reference lists for additional trials. </p> </li> <li> <p>We checked the bibliographies of included studies and any relevant systematic reviews identified for further references to relevant trials. </p> </li> <li> <p>Where necessary, we contacted authors of key papers and abstracts to request additional information about their trials. </p> </li> </ul> </p> <p><b>Searches carried out for previous versions of this review</b> </p> <p>Trial search: Parijs and colleagues published the first RCT of the effect of sodium reduction on BP in 1973 (<a href="./references#CD004022-bbs2-0001" title="ParijsJ , JoossensJV , Van der LindenL , VerstrekenG , AmeryAKPC . Moderate sodium restriction and diuretics in the treatment of hypertension. American Heart Journal1973;85:22-34. ">1000 Parijs 1973 (H)</a>). In our first metaâanalysis (<a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a>), a literature search in MEDLINE (1966âthrough December 1997) was performed using the following combinations of search terms: 1) salt or sodium, 2) restriction or dietary, 3) blood pressure or hypertension, 4) randomized or random. We combined 1, 2, 3 and 4 and found 291 references. Of these, 76 randomised trials from 60 references met the inclusion criteria. From the reference lists of these articles and from four previous metaâanalyses (<a href="./references#CD004022-bbs2-0280" title="GrobbeeDE , HofmanA . Does sodium restriction lower blood pressure?BMJ1986;293:27-9.">Grobbee 1986</a>, <a href="./references#CD004022-bbs2-0295" title="LawM , FrostCD , WaldNJ . . By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.. BMJ1991;302:819-24.">Law 1991</a>, <a href="./references#CD004022-bbs2-0256" title="CutlerJA , FollmannD , ElliotP , SuhI . An overveiw of randomised trials of sodium reduction and blood pressure. Hypertension1991;17 (suppl 1):I27-33.">Cutler 1991</a>, <a href="./references#CD004022-bbs2-0299" title="MidgleyJP , MatthewAG , GreenwoodCMT , LoganAG . Effect of reduced dietary sodium on blood pressure. A meta-analysis of randomised controlled trials. JAMA1996;275:1590-7.">Midgley 1996</a>), an additional 23 references reporting on 39 trials were identified, resulting in a total of 83 references. </p> <p>Similar searches were made for hormones and lipids changing the third search term (blood pressure or hypertension) with the hormone or lipid term resulting in additional five subâstudies dealing with hormones and lipids (<a href="./references#CD004022-bbs2-0221" title="JulaAM , RÃ¶nnemaaT , TikkanenI , KarankoHM . Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension. Journal of Internal Medicine1992;231(5):521-9. ">JulaâKaranko 1992</a>, <a href="./references#CD004022-bbs2-0222" title="JulaAM , RÃ¶nnemaaT , PihaSJ , MÃ¥kiJP . Response of diastolic blood pressure to long-term sodium restriction is posture related. Scandinavian Journal of Clinical and Laboratory Investigation1992;52(3):159-67. ">JulaâMÃ¤ki 1992</a><a href="./references#CD004022-bbs2-0024" title="KoolenMI , BrummelenP . Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension1984;6:820-5. ">1026 Koolen 1984(2)</a>, <a href="./references#CD004022-bbs2-0090" title="OverlackA , RuppertM , KollochR , KraftK , GÃ¶belB , StumpeKO . Divergent hemo dynamic and hormonal responses to varying salt intake in normotensive subjects. Hypertension1993;22:331-8. ">1104 Overlack 1993</a>, <a href="./references#CD004022-bbs2-0228" title="RuppertM , OverlackA , KollochR , KraftK , LennarzM , StumpeKO . Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults. American Journal of the Medical Sciences1994;307(Suppl 1):S87-90. ">Ruppert 1994</a>). Of these 88 references, three dealing exclusively with diabetes patients were excluded in the 2003 update (<a href="./references#CD004022-bbs2-0219" title="DodsonPM , BeeversM , HallworthR , WebberleyMJ , FletcherRF , TaylorKG . Sodium restriction and blood pressure in hypertensive type II diabetics: randomised blind controlled and crossover studies of moderate sodium restriction and sodium supplementation. BMJ1989;298:227-30. ">Dodson 1989</a>, <a href="./references#CD004022-bbs2-0224" title="MulhauserI , PrangeK , SawickiPT , BenderR , DworschakA , SchadenW , et al. Effects of dietary sodium on blood pressure in IDDM patients with nephropathy. Diabetologia Diabetologia1996;39:212-9. ">MÃ¼hlhauser 1996</a>, <a href="./references#CD004022-bbs2-0223" title="MillerJA . Renal responses to sodium restriction in patients with early diabetes mellitus. Journal of the American Society of Nephrology1997;8(5):749-55. ">Miller 1997</a>). </p> <p>In January 2002, a repeated search was performed through December 2001, revealing an additional 12 references, of which one was excluded because it only included patients with diabetes (<a href="./references#CD004022-bbs2-0220" title="ImanishiM , YoshiokaK , OkumuraM , KonishiY , OkadaN , MorikawaT , et al. Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients. Diabetes Care2001;24(1):111-6. ">Imanishi 2001</a>). Accordingly, the 2004 updated review included a total of 96 references. </p> <p>In December 2009, a literature search for the 2011 update was performed from 1950 through December 2009. This search revealed a total of 511 references in Ovid MEDLINE, 282 in Ovid EMBASE and 1428 in Cochrane CENTRAL. Headlines and abstracts were read and 44 articles from MEDLINE (26 included), eight from Embase (one included) and 129 from CENTRAL (45 included) were retrieved as fullâtext papers for further review. A total of 72 new references investigating at least one of the effect variables met the inclusion criteria for this review. The search was not limited to English language studies. Two studies in Italian were identified and included. During the present revision, we discovered that in a few of the previously included studies, some subgroup data were published in two papers. To avoid duplication due to including subgroup data from several papers, we included them from the main paper only. As a result, three previously included references were excluded (<a href="./references#CD004022-bbs2-0229" title="SteegersEA , Van LakwijkHP , JongsmaHW , FastJH , De BooT , EskesTK , et al. (Patho)physiological implications of chronic dietary sodium restriction during pregnancy; a longitudinal prospective randomized study. British Journal of Obstetrics and Gynaecology1991;98:980-7. ">Steegers 1991</a>, <a href="./references#CD004022-bbs2-0227" title="RuppertM , DiehlJ , KollochR , OverlackA , KraftK , GÃ¶belB , et al. Short term dietary sodium restriction increases serum lipids and insulin in salt-sensitive and salt-resistant normotensive adults. Klinische Wochenschrift1991;69(suppl 25):51-7. ">Ruppert 1991</a>, <a href="./references#CD004022-bbs2-0228" title="RuppertM , OverlackA , KollochR , KraftK , LennarzM , StumpeKO . Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults. American Journal of the Medical Sciences1994;307(Suppl 1):S87-90. ">Ruppert 1994</a>). The most recent search was performed on July 21, 2011, revealing 293 additional references. After screening of titles and abstracts, four fullâtext papers were retrieved, of which two contained data to be included. Consequently a total of 167 studies were supposed to be included in the 2011 updated version of this systematic review. However, in connection with the present update, a recount revealed a counting error, as the number of references in reality was 166. </p> <p>During the 2017 update, we identified two studies with duplicate data, which were subsequently excluded (<a href="./references#CD004022-bbs2-0221" title="JulaAM , RÃ¶nnemaaT , TikkanenI , KarankoHM . Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension. Journal of Internal Medicine1992;231(5):521-9. ">JulaâKaranko 1992</a>;<a href="./references#CD004022-bbs2-0222" title="JulaAM , RÃ¶nnemaaT , PihaSJ , MÃ¥kiJP . Response of diastolic blood pressure to long-term sodium restriction is posture related. Scandinavian Journal of Clinical and Laboratory Investigation1992;52(3):159-67. ">JulaâMÃ¤ki 1992</a>), as all data could be extracted from a later paper (<a href="./references#CD004022-bbs2-0094" title="JulaAM , KarankoHM . Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild to moderate essential hypertension. Circulation1994;89:1023-31. ">1110 Jula 1994 (H)</a>). </p> <p>In September 2014, a literature search for the 2017 update was performed as described in "Search methods for identification of studies". The deâduplicated results from the searches revealed 626 articles. On the basis of titles, 549 were excluded. Seventyâseven abstracts were read and 27 fullâtext articles obtained, of which, nine fulfilled the inclusion criteria. In a supplementary search in April 15 2015, an additional 102 references were identified. Six articles were obtained, of which three fulfilled the inclusion criteria.The last updated search was performed on 7 March 2016. The deâduplicated results from the searches revealed 994 articles. During the primary screening, 687 were excluded and on the basis of titles and abstracts, a further 236 articles were eliminated. Seventyâone abstracts were read in detail and 29 fullâtext articles obtained, of which, seven fulfilled the inclusion criteria. Additionally, two articles were identified from a reference list of a review article. A WHO International Clinical Trials Registry Platform search using the search term âdiet and sodiumâ revealed 141 trials, but none were included. </p> <p>A total of 185 references (164 from the 2011 review plus 9 + 3 + 9 new references) were thus included in the updated 2017 version. </p> </section> </section> <section id="CD004022-sec-0026"> <h3 class="title" id="CD004022-sec-0026">Data collection and analysis</h3> <section id="CD004022-sec-0027"> <h4 class="title">Selection of studies</h4> <p>See <a href="#CD004022-sec-0023">Search methods for identification of studies</a>. </p> <p>Review author NG performed the study selection for the 1998 version (<a href="./references#CD004022-bbs2-0322" title="Graudal, NA, GallÃ¸e, AM, Garred, P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. JAMA1998;279(17):1383-91.">Graudal 1998</a>) and the 2003 version (<a href="./references#CD004022-bbs2-0325" title="JÃ¼rgensG , GraudalNA . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. Cochrane Database of Systematic Reviews2003, Issue 1. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub2]">JÃ¼rgens 2003</a>). Review authors NG and GJ independently performed the supplementary study selection for the 2011 version (<a href="./references#CD004022-bbs2-0323" title="GraudalN , Hubeck-GraudalT , JÃ¼rgensG . Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database of Systematic Reviews2011, Issue 11. Art. No: CD004022. [DOI: 10.1002/14651858.CD004022.pub3]">Graudal 2011</a>. NG and THG independently performed the supplementary study selection for the 2017 version and the current version. Discrepancies were resolved by agreement. </p> </section> <section id="CD004022-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>Two authors independently recorded the following data from each trial:</p> <p> <ol id="CD004022-list-0003"> <li> <p>the sample size (N);</p> </li> <li> <p>the mean age of participants;</p> </li> <li> <p>the fraction of females andÂ males; White, BlackÂ and Asian participants;</p> </li> <li> <p>the duration of the intervention;</p> </li> <li> <p>the sodium reduction measured as the difference between 24âhour urinary sodium excretion during lowâsodium and highâsodium diets and standard deviation (SD); </p> </li> <li> <p>SBP (SD) and DBP (SD) before and after intervention;</p> </li> <li> <p>difference between changes in SBP and DBP obtained during lowâsodium and highâsodium diets and the SD of these differences; </p> </li> <li> <p>for crossâover studies, when possible, the overall effect estimate and standard error (SE); </p> </li> <li> <p>levels of hormones and lipids in the blood and their standard deviations during lowâsodium and highâsodium diets. Concerning lipids, cholesterol units of mmol/L were transformed to mg/dL by means of the factor 38.6 and triglyceride units of mmol/L were transformed to mg/dL by means of the factor 88.4. Other renin units than ng/mL/hour were when possible transformed to ng/mL/hour, and units of aldosterone, noradrenalin and adrenalin other than pg/mL were transformed to pg/mL by means of the molecular weights. </p> </li> <li> <p>Assessment of risk of bias data</p> </li> </ol> </p> <p>If there were discrepancies between review authors they looked at the data together and came to an agreement. </p> </section> <section id="CD004022-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>This was performed using the Cochrane 'Risk of bias' tool described in Chapter 8 of the Cochrane Handbook for Systematic Reviews of Interventions (<a href="./references#CD004022-bbs2-0285" title="HigginsJP , GreenS , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2011.">Higgins 2011</a>) including recording of allocation, blinding, incomplete outcome data and selective reporting. Blinding was recorded as defined by the study authors (blinding) and as assessed by the present review authors (performance bias and detection bias). </p> </section> <section id="CD004022-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>No outcomes were dichotomous, but all were continuous. Consequently, the outcome measure was defined as the mean difference (MD) with 95% confidence intervals (CI) between the changes from baseline to end of treatment during lowâ and highâsodium diets. </p> </section> <section id="CD004022-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <section id="CD004022-sec-0032"> <h5 class="title">Blood pressure (BP)Â </h5> <p>Combined analyses were performed including both parallel and crossâover studies. The generic inverse variance data type was used to analyse the effect in order to ensure that the weight of the crossâover studies was not underestimated compared with the parallel studies. For parallel studies, the SE was calculated in the usual way as follows: SE (diff) = sqrt SE<sub>1</sub><sup>2</sup> + SE<sub>2</sub><sup>2</sup>. For crossâover studies the given SE (difference) was used. In case the SE (difference) was not reported, it was estimated by a linear regression equation linking the given SE to the calculated SE (sqrt SE<sub>1</sub><sup>2</sup> + SE<sub>2</sub><sup>2</sup>) by means of the studies which reported both SE (difference) and SE on BP during both intervention periods. This regression equation was used to transform all SEs calculated by (sqrt SE<sub>1</sub><sup>2</sup> + SE<sub>2</sub><sup>2</sup>) to estimated âtrueâ SEs (difference) in crossâover studies that did not report SE (difference). In this way, it was ensured that crossâover studies were attributed proper weight compared with the parallel studies. There were not enough studies to calculate separate equations for Black and Asian populations and therefore the equations calculated in the white populations were used to transform these SEs when necessary. </p> </section> <section id="CD004022-sec-0033"> <h5 class="title">Hormones and lipids</h5> <p>The very few parallel studies were excluded and the large fraction of crossâover studies were analysed separately. As the large majority of crossâover studies reported separate data for each intervention period instead of overall estimates of effect, the continuous data type was used in the separate analyses of the crossâover studies. </p> </section> </section> <section id="CD004022-sec-0034"> <h4 class="title">Dealing with missing data</h4> <p>If the SD was not reported it was calculated from a given SE, 95% confidence interval (CI), P value or t value, estimated from a figure or imputed from the formula SD (change) = sq root (SD1sq + SD2sq), SD1 is SD on blood pressure before intervention and SD2 is SD on blood pressure after intervention. </p> </section> <section id="CD004022-sec-0035"> <h4 class="title">Assessment of heterogeneity</h4> <p>A Chi<sup>2</sup> test included in the forest plot was used to assess whether observed differences in results are compatible with chance alone. A low P value (or a large Chi<sup>2</sup> statistic relative to its degree of freedom) provides evidence of heterogeneity of intervention effects (variation in effect estimates beyond chance). The Chi<sup>2</sup> statistic can be transformed to a statistic (I<sup>2</sup>), which describes the percentage of the variability in effect estimates that is due to heterogeneity rather than sampling error (Higgins 2011). The I<sup>2</sup> value can be interpreted as less important (0â40%), moderate 30â60%, substantial 50â90% and considerable (75â100%) (Higgins 2011). The I<sup>2</sup> value was used to describe the percentage of heterogeneity in the individual analyses. </p> </section> <section id="CD004022-sec-0036"> <h4 class="title">Assessment of reporting biases</h4> <p>For studies reporting SBP and DBP we evaluated whether the studies did not report other variables, which might have been mentioned in the methods or a protocol, i.e. whether there was selective reporting of outcome variables in the individual studies. </p> <p>To analyse the possibility of publication bias, Funnel plots were assessed for asymmetry. Higgins states that as a rule of thumb, tests for funnel plot asymmetry should be used only when there are at least 10 studies included in the metaâanalysis, because when there are fewer studies the power of the tests is too low to distinguish chance from real asymmetry (Higgins 2011). Therefore, we did not assess funnel plots for black and Asian study populations </p> </section> <section id="CD004022-sec-0037"> <h4 class="title">Data synthesis</h4> <p>Individual study data defined before randomisation based on race and state of hypertension were included in separate metaâanalyses, whereas sodium sensitivity subgroups, which were defined by the authors of the individual studies after they had analysed the data, were combined by the present authors, and subsequently the combined data were included in the metaâanalyses. </p> <p>The mean difference (MD) was calculated for outcome measures with identical units in the included studies (BP without transformation of data (all measured as mmHg), renin, adrenaline, aldosterone, noradrenalin and lipids, after transformation). In this version we transformed the outcomes of 14 studies which reported renin as concentrations (mU/L) to renin as activities (ng/ml/h) by division with 8.2 (the regression coefficient assessed from the regression line associating renin concentration (mU/L) with renin activity (ng/ml/h) in figure 2 in <a href="./references#CD004022-bbs2-0259" title="deBruinRA , BouhuizenA , DiederichS , PerschelFH , BoomsmaF , Deinum J. Validation of a new automated renin assay.. Clin Chem.2004;50:2111-6.">De Bruin 2004</a>). After this transformation only three studies was left in which there was no information to decide the unit of the outcome. These studies were excluded from the statistical analysis (1080 Huggins 1992 (increase from 6.1 to 8.6 during sodium reduction);1146 Herlitz 1998 (H)(increase from 1.7 to 19.6 during sodium reduction); 1234 Twist 2016 (H) (increase from 15.2 to 18.6 during sodium reduction)). Thus reninâoutcome in this version is reported as MD and not as SMD. </p> <p>As we accumulated data from a series of studies that had been performed by researchers operating independently, and as the goal of the analysis was to extrapolate to other populations, we used a randomâeffects model in our primary analysis to estimate the summary measure as the mean of a distribution of effects. </p> <p>Level of significance: In case of multiple independent comparisons, it is important to avoid coincidental significance. Ten metaâanalyses were performed. However, the SBP and DBP comparisons are not independent of each other and BP depends on renin and aldosterone as well as catecholamines. Concerning lipids, these are mutually dependent, whereas the dependency on BP and hormones is not obvious. Consequently, the 10 metaâanalyses could be subâclassified into a group of metaâanalyses of mutually dependent BP and hormones and an independent group of metaâanalyses of mutually dependent lipid fractions. Consequently, the level of significance was reduced by means of the formula 1â0.95 x 1/N = 1â0.95 x 1/2 = 0.025, (N = number of independent investigations = 2). </p> </section> <section id="CD004022-sec-0038"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We prevented some heterogeneity by stratifying by race and BP. Furthermore, study duration might explain some heterogeneity. There is reasonable evidence to determine the time of maximal efficacy to be one week (<a href="http://Table 2" target="_blank">Table 2</a>). Therefore, there is a risk that studies lasting for less than one week may underestimate the effect of sodium reduction. Furthermore, evidence has appeared to indicate that all of the worldâs populations have a mean sodium intake below 250 mmol/day (<a href="http://Table 1" target="_blank">Table 1</a>), and as doseâresponse studies have indicated that sodium reductions from very high levels have bigger effects than reductions from usual levels (Graudal 2015), such studies may contribute to overestimate the effect. We therefore performed a subgroup analysis intending to eliminate these potential biases on SBP and DBP (stratified according to normal BP or hypertension) and renin, aldosterone, noradrenalin, adrenalin, cholesterol triglyceride, HDL and LDL by exclusion of studies with a duration of less than seven days and sodium intake above 250 mmol/day. The subgroup analysis on SBP and DBP was performed in studies of white participants only. As all studies in Asian and black participants except 3 lasted at least 7 days it was not meaningful to make a subâanalysis in this small group of studies. </p> <p>Sources of bias: To investigate possible heterogeneity due to methodological diversity, subgroup analyses of the primary analysis of SBP were performed for contrasting sources of bias appearing from the 'Risk of bias' analysis. </p> </section> <section id="CD004022-sec-0039"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were performed 1) excluding studies with extreme positive and negative outcomes in order to analyse the effect of reducing heterogeneity, and 2) including studies, which were excluded from the primary analysis due to undefined outcome units or study design differences (parallel versus crossâover). In order not to underestimate the effect of the excluded parallel studies, these were included in the sensitivity analyses without adjusting the weight of the study to that of a crossâover study of similar size. </p> </section> <section id="CD004022-sec-0040"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>Outcomes (effect on SBP and DBP in normotensive and hypertensive white, blackÂ and Asian populations, effect on hormones and on lipids) is reported in summary of findings tables, which will show the mean differences (95% CI), number of participants and the certainty of the effect sizes estimated by the GRADE system. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD004022-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD004022-sec-0041"></div> <section id="CD004022-sec-0042"> <h3 class="title">Description of studies</h3> <p>Fortyâsix studies did not mention support. One hundred and twentyânine studies were supported by public foundations. Twelve studies were supported by the pharmaceutical industry. Six studies were supported by food industry organisations. Two studies were supported by companies unassociated with the pharmaceutical or food industry. Nineteen mixed populations were classified as white and 3 as black. </p> <section id="CD004022-sec-0043"> <h4 class="title">Results of the search</h4> <p>April 11th 2018, a literature search for the present update was performed as described in "Search methods for identification of studies". The deâduplicated results from the searches revealed 877 articles. During the primary screening 561 were excluded. 316 abstracts were read, and 39 fullâtext articles obtained, of which 10 fulfilled the inclusion criteria. A total of 195 references (185 from the 2017 review plus 10 new references) were thus included in the present updated version. These 195 references included 225 study populations. A topâup search covered the period from March 9, 2016 to March 18, 2020 and revealed 2222 references and after deâduplication 1448 remained. Compared versus previous searches 605 were duplicates and were removed. Thus, compared with the complete April 11, 2018 search, the topâup search identified 843 new references. After a primary screening 271 were eliminated. Based on a screening of abstracts 538 of the remaining 572 articles were excluded. Thus 34 fullâtext articles were reviewed and of these 12 fulfilled criteria for inclusion. These 12 references are not included in the present version but are placed under âstudies awaiting classificationâ </p> </section> <section id="CD004022-sec-0044"> <h4 class="title">Included studies</h4> <p>See <a href="./references#CD004022-sec-0086" title="">Characteristics of included studies</a>Â and <a href="#CD004022-tbl-0008">Table 3</a> (Acronyms used in table "Characteristics of included studies") </p> <div class="table" id="CD004022-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Acronyms used in table "Characteristics of included studies"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adrenaline</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aldo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aldosterone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CrossâOver</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DBP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diastolic blood pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Duration</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High density lipoprotein</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyp</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hypertension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention to treat</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low density lipoprotein</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LoFo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lost to followâup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MAP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean arterial pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>M/F</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male/Female</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normotension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Noradrenaline</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Op</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Parallel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>S</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Single blind</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SBP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systolic blood pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium reduction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Triglyceride</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>W/B/A:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of white participants/ black participants/ Asian participants</p> </td> </tr> </tbody> </table> </div> <p>One hundred and ninetyâfive references were included in the review. Eight included only data on hormones and lipids, whereas 187 included BP data, as well as hormone and lipid data in a significant number of these. The total number of study populations with BP outcomes included in the primary analysis was 217. The median of the mean ages was 43 years (range: 12 to 73), which is a little higher than the median age of most populations (typically 35 years) and the mean sodium intake in the highâsodium group was 203 mmol/day (SD: 66) and in the lowâsodium group was 65 mmol/day (SD: 40), corresponding to a mean sodium reduction of 138 mmol/day.The median of the mean ages of the study's 131 white populations included in the subgroup analysis (duration of at least seven days, a sodium intake of less than 250 mmol/day) was 45 years (range: 13 to 73) the mean sodium intake in the highâsodium group was 178 mmol/day (SD: 35) and in the lowâsodium group was 68 mmol/day (SD: 36), corresponding to a mean sodium reduction of 110 mmol/day. The mean BP in the normotensive study populations was 119/71 mmHg, which is close to the population mean of the USA population (119/71 mmHg) (<a href="./references#CD004022-bbs2-0320" title="WrightJD , Hughes, JP, OstchegaY , YoonSS , NwankwoT . Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001â2008. National Health Statistics Report2011;35:1-24.">Wright 2011</a>), and a little higher than the mean of the normotensive fraction of the USA population (115/70 mmHg) (<a href="./references#CD004022-bbs2-0320" title="WrightJD , Hughes, JP, OstchegaY , YoonSS , NwankwoT . Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001â2008. National Health Statistics Report2011;35:1-24.">Wright 2011</a>). The mean BP in the untreated hypertensive study populations was 151/94 mmHg and in the treated hypertensive study populations was 143/88 mmHg, both of which are higher than corresponding pressures in the USA population (146/84 mmHg and 131/72 mmHg) (<a href="./references#CD004022-bbs2-0320" title="WrightJD , Hughes, JP, OstchegaY , YoonSS , NwankwoT . Mean systolic and diastolic blood pressure in adults aged 18 and over in the United States, 2001â2008. National Health Statistics Report2011;35:1-24.">Wright 2011</a>). </p> <p>In 88 study populations including 7383 participants, there was information of the baseline 24âhour sodium excretion, not influenced by diets. This was 158,7 mmol/24âhour (range: 90â274 mmol) (10â90 percentiles: 123â192 mmol). </p> </section> <section id="CD004022-sec-0045"> <h4 class="title">Excluded studies</h4> <p>See <a href="./references#CD004022-sec-0087" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD004022-sec-0046"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="./references#CD004022-sec-0086" title="">Characteristics of included studies</a> and <a href="#CD004022-fig-0001">Figure 1</a> </p> <div class="figure" id="CD004022-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004022-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <p>The obligatory trial quality criterion was randomisation. Doubleâblind, singleâblind or open studies with a parallel or a crossâover design were accepted. A study was defined as singleâblind if an investigator measured BP without knowledge of the diet or by a computerised manometer, and as open if precautions to decrease observer bias were not mentioned. </p> <p>We found two important contrasts: general blinding and blinding of outcome detection (<a href="#CD004022-fig-0001">Figure 1</a>). We performed subgroup analyses of BP in both normotensive and hypertensive white populations, but not in the black and Asian populations due to the small numbers of trials. We did not perform subgroup analyses on the biochemical outcomes (hormones and lipids) as they are supposed to be performed blindly in 100% of cases. </p> <section id="CD004022-sec-0047"> <h4 class="title">Allocation</h4> <p>Only 16 studies (1034 Watt 1985; 1078 Egan 1991 (H); 1081 TOHP I 1992; 1107 MacFadyen 1994;1135 TOHP II 1997; 1136 van Buul 1997;1142 Knuist 1998; 1195 Jessani 2008; 1197 Dickinson 2009; 1198 He 2009 W (H); 1206 Graffe 2012; 1208 Todd 2012; 1217 Markota 2015 (H); 1225 Gijsbers 2015 (H); 1229 He 2015; 1232 Nielsen 2016), either partly or sufficiently explained the allocation sequence generation and concealment. Consequently, there is a general significant risk that allocation could be biased. </p> </section> <section id="CD004022-sec-0048"> <h4 class="title">Blinding</h4> <p>Seventyâtwo study populations were reported to be doubleâblind by the authors (general blinding), and in 140 study populations we assessed the risk of detection bias to be low (<a href="#CD004022-fig-0001">Figure 1</a>). Separate analyses were performed on studies with low and high risks of general blinding and outcome detection in white populations. </p> </section> <section id="CD004022-sec-0049"> <h4 class="title">Incomplete outcome data</h4> <p>Based on the information given in the individual articles, the risk of reporting participants with incomplete outcome data generally was small, about 20% being unclear or high (<a href="http://Figure 1" target="_blank">Figure 1</a>). However, only a few studies showed flow charts of the fate of the participants. Therefore, this bias may be significant. </p> </section> <section id="CD004022-sec-0050"> <h4 class="title">Selective reporting</h4> <p>Based on the information given in the individual articles, selective outcome reporting bias on the study level was small, about 10% being unclear or high (<a href="http://Figure 1" target="_blank">Figure 1</a>). However, as protocols did not exist for the vast majority of studies, this evaluation may be imprecise. </p> <p>Potential publication bias assessed by inspection of Funnel plots is described below for each outcome. </p> </section> <section id="CD004022-sec-0051"> <h4 class="title">Other potential sources of bias</h4> <p>The effect of an intervention on BP may depend on factors such as baseline BP and race. Therefore, a biased distribution of such factors in the included study populations compared with the general population may bias the effect of the intervention found in the metaâanalysis to be different from the potential effect in the general population. We therefore performed separate analyses for hypertensive and normotensive individuals and for different races. </p> </section> </section> <section id="CD004022-sec-0052"> <h3 class="title" id="CD004022-sec-0052">Effects of interventions</h3> <p>See: <a href="./full#CD004022-tbl-0001"><b>Summary of findings 1</b> Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in white participants</a>; <a href="./full#CD004022-tbl-0002"><b>Summary of findings 2</b> Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in black participants</a>; <a href="./full#CD004022-tbl-0003"><b>Summary of findings 3</b> Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in Asian participants</a>; <a href="./full#CD004022-tbl-0004"><b>Summary of findings 4</b> Summary of findings: Low sodium intake compared with high sodium intake for hormones</a>; <a href="./full#CD004022-tbl-0005"><b>Summary of findings 5</b> Summary of findings: Low sodium intake compared with high sodium intake for lipids</a> </p> <p>See <a href="./references#CD004022-sec-0074" title="">Data and analyses</a>. </p> <section id="CD004022-sec-0053"> <h4 class="title">Blood pressure in white participants</h4> <p>See <a href="http://Summary of findings table 1" target="_blank">Summary of findings table 1</a> </p> <p>In the metaâanalyses of trials of white participants with normal blood pressure (BP), the mean difference (MD) was a change in systolic blood pressure (SBP) of â1.14 mmHg (95% CI: â1.65 to â0.63) (P = 0.0001) (95 trials, 9077 participant measurements (5982 participants)) (<a href="http://Analysis 1.1" target="_blank">Analysis 1.1</a>; <a href="#CD004022-fig-0002">Figure 2</a>), and in diastolic blood pressure (DBP) of + 0.01 mmHg (95% CI: â0.37 to 0.39) (P = 0.96) (96 trials, (9341 participant measurements,(6276 participants)) (<a href="http://Analysis 1.2" target="_blank">Analysis 1.2</a>; <a href="#CD004022-fig-0003">Figure 3</a>) (<i>highâquality evidence)</i>. </p> <div class="figure" id="CD004022-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, SBP." data-id="CD004022-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, SBP. </p> </div> </div> </div> <div class="figure" id="CD004022-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, DBP." data-id="CD004022-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, DBP. </p> </div> </div> </div> <p>In subgroup metaâanalyses of trials with a duration of at least one week and a sodium intake of a maximal 250 mmol/day, the MD showed a decrease in SBP of â1.38 mmHg (â1.87 to â0.89) (P = 0.00001) (63 trials, 7433 participant measurements,5186 participants) (<a href="http://Analysis 4.1" target="_blank">Analysis 4.1</a>) and in DBP of â0.37 mmHg (95% CI: â0.78, 0.04) (P = 0.08) (64 trials, 7697 participant measurements,5480 participants) (<a href="http://Analysis 4.2" target="_blank">Analysis 4.2</a>). </p> <p>In all analyses (1.1, 1.2, 4.1 and 4.2) the I<sup>2</sup> value decreased, when the four most extreme negative and positive effects were eliminated from the analysis without changing the overall effect: 1.1: From 69% to 40% (Effect from â1.14 mmHg to â1.32 mmHg), 1.2: From 60% to 40% (Effect from 0.04mmHg to â0.11mmHg), 4.1: From 55% to 29% (Effect from â1.38 mmHg to â1.26 mmHg), 4.2: From 52% to 17% (Effect from â0.37 mmHg to â0.40 mmHg). </p> <p>In the trials of white people with elevated BP, MD showed a decrease in SBP of â5.71 mmHg (95% CI: â6.67 to â4.74) (P &lt; 0.00001) (88 trials, 6116 participant measurements (3998 participants)) (<a href="http://Analysis 1.3" target="_blank">Analysis 1.3</a>), and in DBP of â2.87 mmHg (95% CI: â3.41 to â2.32) (P &lt; 0.00001) (89 trials, 6140 participant measurements (4032 participants) (<a href="http://Analysis 1.4" target="_blank">Analysis 1.4</a>) (<i>highâquality evidence</i>). </p> <p>In subgroup metaâanalyses of trials with a duration of at least one week and a sodium intake of a maximal 250 mmol/day, MD showed a decrease in SBP of â5.32 mmHg (â6.36 to â4.28) (P &lt; 0.00001) (66 trials, 5274 participant measurements, 3645 participants) ( <a href="http://Analysis 4.3" target="_blank">Analysis 4.3</a>) and in DBP of â2.76 mmHg (95% CI: â3.38 to â2.13) (P &lt; 0.00001) (67 trials, 5298 participant measurements, 3657 participants ) (<a href="http://Analysis 4.4" target="_blank">Analysis 4.4</a>). </p> <p>Elimination of four extreme positive and negative effects also reduced I<sup>2</sup> but to a lesser degree degree without changing the outcomes: 1.3: From 77% to 65% (Effect from â5.71 mmHg to â5.34 mmHg), 1.4: From 66% to 50% (Effect from â2.87 mmHg to â2.71 mmHg), 4.3: From 72% to 53% (Effect from â5.32 mmHg to â4.79 mmHg), 4.2: From 68% to 46% (Effect from â2.76 mmHg to â2.52 mmHg). </p> <p>The BP funnel plots were asymmetric with missing values in the lower left corner for normotensives and in the lower right corner for hypertensive studies. </p> <p>Bias analysis: Comparing low bias risk versus high/unclear bias risk of general blinding and blinding of outcome detection for SBPâoutcomes in white people with normotension and hypertension showed no important differences (Data and analyses: 9 Bias analyses). </p> </section> <section id="CD004022-sec-0054"> <h4 class="title">Blood pressure in black participants</h4> <p>See <a href="http://Summary of findings table 2" target="_blank">Summary of findings table 2</a> </p> <p>In the metaâanalyses of seven crossâover trials involving 253 black participants (506 participant measurements) with normal BP, MD showed a decrease in SBP of â4.02 mmHg (95% CI:â7.37 to â0.68) (P = 0.02) (<a href="http://Analysis 2.1" target="_blank">Analysis 2.1</a>) and in DBP of â2.01 mmHg (95% CI:â4.37, 0.35) (P = 0.09) (<a href="http://Analysis 2.2" target="_blank">Analysis 2.2</a>) (low<i>âquality evidence</i>). </p> <p>In the metaâanalyses of six crossâover and two parallel trials of 398 black participants with elevated BP (619 participant measurements), MD showed a decrease in SBP of â6.64 mmHg (95% CI:â9.00, â4.27) (P = 0.00001) (<a href="http://Analysis 2.3" target="_blank">Analysis 2.3</a>) and in DBP of â2.91 mmHg (95% CI:â4.52, â1.30) (P = 0.0004) (<a href="http://Analysis 2.4" target="_blank">Analysis 2.4</a>) (low<i>âquality evidence</i>). </p> <p>The results are inconsistent as each of these groups could be separated in two subgroups with large and small effects, each having very low I<sup>2</sup> values, whereas the combined group had very high I<sup>2</sup>values. </p> </section> <section id="CD004022-sec-0055"> <h4 class="title">Blood pressure in Asian participants</h4> <p>See <a href="http://Summary of findings table 3" target="_blank">Summary of findings table 3</a> </p> <p>In the metaâanalyses of three parallel and two crossâover trials involving 950 Asian participants (973 participant measurements) with normal BP, MD showed a decrease in SBP of â1.50 mmHg (95% CI: â3.09, 0.10) (P = 0.07) (<a href="http://Analysis 3.1" target="_blank">Analysis 3.1</a>) and in DBP of â1.06 mmHg (95% CI:â2.53 to 0.41) (P= 0.16) (<a href="http://Analysis 3.2" target="_blank">Analysis 3.2</a>) (<i>moderateâquality evidence</i>).) </p> <p>In the metaâanalyses of six crossâover and two parallel studies involving 254 Asian participants (501 participant measurements) with elevated BP, MD showed a decrease in SBP of of â7.75 mmHg (95% CI:â11.44, â4.07) (P &lt; 0.0001) (<a href="http://Analysis 3.3" target="_blank">Analysis 3.3</a>) and in DBP of â2.68 mmHg (95% CI: â4.21 to â1.15)(P = 0.0006) (<a href="http://Analysis 3.4" target="_blank">Analysis 3.4</a>) (low<i>âquality evidence</i>). </p> <p>The outcomes of the normotensive study populations were homogenous (I<sup>2</sup> =0), but the outcomes of the hypertensive populations were inconsistent as each of these groups could be separated in two subgroups with large and small effects, each having very low I<sup>2</sup> values, whereas the combined group had very high I<sup>2</sup>values. </p> </section> <section id="CD004022-sec-0056"> <h4 class="title">Renin</h4> <p>See <a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a> </p> <p>Four parallel trials were excluded (1110 Jula 1994 (H) (renin increase from 0.7 to 1.1 ng/ml/h during sodium reduction), 1155 Heer 2000 (renin increase from 20,4 to 76.1 mikroU/ml during sodium reduction);1226 Cavka 2015 (renin increase from 0.87 to 1.99 ng/ml/h during sodium reduction); 1228 Jablonski 2013 (H) (renin increase from 0.84 to 1.48 ng/ml/h during sodium reduction)). </p> <p>In the remaining 82 crossâover trials (2904 participants, 5808 participant measurements) of measurement of renin (including 91 comparisons reported in the Data &amp; analyses), MD showed a mean increase of 1.56 ng/ml/h (95% CI: [1.39 to 1.73]) (P &lt; 0.00001) (<a href="http://Analysis 5.1" target="_blank">Analysis 5.1</a>) (<i>highâquality evidence</i>). </p> <p>In comparisons with a duration of at least seven days and a sodium intake of less than 250 mmol/day (46 trials, 1819 participants), MD was 1.29 ng/ml/hour (95% CI: 1.07 to 1.51), (P &lt; 0.00001) (<a href="http://Analysis 6.1" target="_blank">Analysis 6.1</a>). </p> <p>The increase in normotensive participants was higher than in hypertensive participants (<a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a>). </p> <p>A visual inspection of the Forest plot reveals that almost all studies showed an increase in renin, when sodium intake was reduced, indicating a high degree of consistency. Despite this the I<sup>2</sup> value was very high (97%). The funnel plot was asymmetrical with missing values in the lower right corner. </p> <p>Sensitivity analysis: Inclusion of fourÂ parallel trials with full weight contributions and three studies with undefined units using SMD as outcome measure did not change the outcome. </p> </section> <section id="CD004022-sec-0057"> <h4 class="title">Aldosterone</h4> <p>See <a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a> </p> <p>Five parallel trials were excluded (1110 Jula 1994 (H) (aldosterone increase from 297 to 363 pg/ml during sodium reduction); 1111 Howe 1994 (H)(aldosterone increased by 95 pg/ml during sodium reduction); 1155 Heer 2000 (aldosterone increase from 80.7 to 418.1 pg/ml during sodium reduction); 1226 Cavka 2015 (aldosterone increase from 214 to 424 pg/ml during sodium reduction); 1228 Jablonski 2013 (H) (aldosterone was unchanged from 41 to 57 pg/ml during sodium reduction)). </p> <p>In the remaining 66 crossâover trials (2506 participants, 5012 participant measurements) of measurement of aldosterone, MD was 104.02 pg/mL (95% CI: 18.4 to 119.69) (P &lt; 0.00001) (<a href="#CD004022-fig-0004">Figure 4</a>, <a href="http://Analysis 5.2" target="_blank">Analysis 5.2</a>) (<i>highâquality evidence</i>). In comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (35 trials, 1612 participants), MD was 96.64 pg/mL (95% CI: 75.35 to 117.94), P = 0.00001 (<a href="http://Analysis 6.2" target="_blank">Analysis 6.2</a>).The effect in normotensive participants was significantly higher than in hypertensive participants (<a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a>). </p> <div class="figure" id="CD004022-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.2 Aldosterone (pg/mL)." data-id="CD004022-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.2 Aldosterone (pg/mL). </p> </div> </div> </div> <p>A visual inspection of the Forest plot reveals that almost all studies showed an increase in aldosterone, when sodium intake was reduced, indicating a high degree of consistency. Despite this the I<sup>2</sup> value was very high (96%). The funnel plot was asymmetrical with missing values in the lower right corner. </p> <p>Sensitivity analysis: Inclusion of fiveÂ parallel trials with full weight contributions did not change the outcome. </p> </section> <section id="CD004022-sec-0058"> <h4 class="title">Noradrenaline</h4> <p>See <a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a> </p> <p>Two parallel trials were excluded (1110 Jula 1994 (H) (noradrenaline was unchanged from 610 to 520 pg/ml during sodium reduction); 1228 Jablonski 2013 (H) (noradrenaline was unchanged from 392 to 400 pg/ml during sodium reduction)). </p> <p>In the remaining 35 crossâover trials (878 participants, 1756 participant measurements) of measurement of noradrenaline (including 37 comparisons reported in the Data &amp; analyses), MD was 62.33 pg/mL (95% CI: 41.90 to 82.76), (P = 0.00001) (<a href="#CD004022-fig-0005">Figure 5</a>, <a href="http://Analysis 5.3" target="_blank">Analysis 5.3</a>) (<i>highâquality evidence</i>). In comparisons with duration of at least one week and a sodium intake of less than 250 mmol/day (23 studies, 482participants) MD was 48.7 pg/mL (95% CI: 28.9 to 68.4), P = 0.00001 (<a href="http://Analysis 6.3" target="_blank">Analysis 6.3</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a>). </p> <div class="figure" id="CD004022-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.3 Noradrenaline (pg/mL)." data-id="CD004022-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.3 Noradrenaline (pg/mL). </p> </div> </div> </div> <p>A visual inspection of the Forest plot reveals that most studies showed an increase in noradrenalin, when sodium intake was reduced, indicating a high degree of consistency. Despite this the I<sup>2</sup> value was high (74%). The funnel plot was symmetrical </p> <p>Sensitivity analysis: Inclusion of two parallel trials with full weight contributions did not change the outcome. </p> </section> <section id="CD004022-sec-0059"> <h4 class="title">Adrenaline</h4> <p>See <a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a> </p> <p>One parallel trial was excluded (1110 Jula 1994 (H) (adrenaline was reduced by 10 pg/ml during sodium reduction). </p> <p>In the remaining 15 crossâover trials (331 participants, 662 participant measurements) of measurement of adrenaline (including 16 comparisons reported in the Data &amp; analyses), MD was 7.55 pg/mL (95% CI: 0.85 to 14.26), (P = 0.03) (<a href="http://Analysis 5.4" target="_blank">Analysis 5.4</a>) (<i>moderateâquality evidence</i>). In comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (11 studies, 12 comparisons, 243 participants,) MD was 7.79 pg/mL (95% CI: 0.31 to 15.28), P = 0.04 (<a href="http://Analysis 6.4" target="_blank">Analysis 6.4</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 4" target="_blank">Summary of findings table 4</a>). </p> <p>The I<sup>2</sup> value was moderate (58%). The funnel plot was symmetrical </p> <p>Sensitivity analysis: Inclusion of one parallel trial with full weight contribution did not change the outcome (MD = 6.91 pg/ml). </p> </section> <section id="CD004022-sec-0060"> <h4 class="title">Cholesterol</h4> <p>See <a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a> </p> <p>Three parallel trials were excluded (1015 Bulpitt 1984 (H)(No changes during sodium reduction); 1085 Sciarrone 1992 (H)(Minor decrease during sodium reduction); 1199 Meland 2009 (H))(No changes during sodium reduction). In the remaining 27 crossâover trials (917 participants, 1834 participant measurements) of measurement of cholesterol (including 28 comparisons reported in the Data &amp; analyses), MD showed an increase of 5.19 mg/dL (95% CI: 2.07 to 8.32), P = 0.001 (<a href="#CD004022-fig-0006">Figure 6</a>, <a href="http://Analysis 7.1" target="_blank">Analysis 7.1</a>) (high<i>âquality evidence</i>). In comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (21 trials, 1214 participants) MD was 4.31 mg/dL (95% CI: 0.71 to 7.91), P = 0.02 (<a href="http://Analysis 8.1" target="_blank">Analysis 8.1</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a>) </p> <div class="figure" id="CD004022-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 6 Effect of salt reduction on lipids, outcome: 6.1 Cholesterol." data-id="CD004022-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-06.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 6 Effect of salt reduction on lipids, outcome: 6.1 Cholesterol.</p> </div> </div> </div> <p>The I<sup>2</sup> value was low (0 %). The funnel plot was symmetrical. </p> <p>Sensitivity analysis: Inclusion of three parallel trials with full weight contributions did not change the outcome. </p> </section> <section id="CD004022-sec-0061"> <h4 class="title">Triglyceride</h4> <p>See <a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a> </p> <p>Two parallel trials were excluded (1085 Sciarrone 1992 (H)(Minor increase during sodium reduction ; 1199 Meland 2009 (H))(No changes during sodium reduction). </p> <p>In the remaining 20 crossâover trials (712 participants, 1424 participant measurements) of measurement of triglyceride, MD showed an increase of 7.10 mg/dL (95% CI: 3.14 to 11.07), P = 0.0004 (<a href="http://Analysis 7.2" target="_blank">Analysis 7.2</a>) (high<i>âquality evidence</i>). In comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (13 trials, 804 participants) the effect was 7.03 (mg/dL [95% CI: 2.01 to 12.04), P = 0.006 (<a href="http://Analysis 8.2" target="_blank">Analysis 8.2</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a>) </p> <p>The I<sup>2</sup> value was low (0 %). The funnel plot was symmetrical. </p> <p>Sensitivity analysis: Inclusion of two parallel trials with full weight contributions did not change the outcome. </p> </section> <section id="CD004022-sec-0062"> <h4 class="title">Highâdensity lipoprotein (HDL)</h4> <p>See <a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a> </p> <p>Two parallel trials were excluded (1085 Sciarrone 1992 (H)(Minor decrease during sodium reduction); 1199 Meland 2009 (H))(No changes during sodium reduction). </p> <p>In the remaining 20 crossâover trials (738 participants, 1476 participant measurements) of measurement of HDL, there was no effect of sodium reduction on serum HDL: MD: â0.30 mg/dL (95% CI: â1.66 to 1.0) P = 0.66 (<a href="http://Analysis 7.3" target="_blank">Analysis 7.3</a>) (high<i>âquality evidence</i>). This result did not change in comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (â0.68 mg/dL (â2.17 to 0.81), P = 0.37 (15 trials, 982 participants)) (<a href="http://Analysis 8.3" target="_blank">Analysis 8.3</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a>) </p> <p>The I<sup>2</sup> value was low (0 %). The funnel plot was symmetrical. </p> <p>Sensitivity analysis: Inclusion of twoÂ parallel trials with full weight contributions did not change the outcome. </p> </section> <section id="CD004022-sec-0063"> <h4 class="title">Lowâdensity lipoprotein (LDL)</h4> <p>See <a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a> </p> <p>One parallel trial was excluded (1085 Sciarrone 1992 (H))(Minor decrease during sodium reduction). </p> <p>In the remaining 18 crossâover trials (696 participants, 1392 participant measurements) of measurement of LDL, MD showed a nonâsignificant increase of 2.46 mg/dL (95% CI: â0.97, to, 5.9), P = 0.16 (<a href="http://Analysis 7.4" target="_blank">Analysis 7.4</a>)(<i>moderateâquality evidence</i>). In comparisons with duration of at least one week and sodium intake of less than 250 mmol/day (13 trials, 898 participants), MD was 2.74 mgdL (95% CI: â1.18 to 6.66), P = 0.17 (<a href="http://Analysis 8.4" target="_blank">Analysis 8.4</a>). There was no difference between normotensive participants and hypertensive participants (<a href="http://Summary of findings table 5" target="_blank">Summary of findings table 5</a>) </p> <p>The I<sup>2</sup> value was low (0 %). The funnel plot was symmetrical. </p> <p>Sensitivity analysis: Inclusion of oneÂ parallel trial with full weight contribution did not change the outcome. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD004022-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD004022-sec-0064"></div> <section id="CD004022-sec-0065"> <h3 class="title" id="CD004022-sec-0065">Summary of main results</h3> <p>The GRADE of the evidence was generally high with the exception of the small blood pressure analyses of the few black and Asian study populations, which were assessed to be of low or moderate GRADE. </p> <p>The effect of sodium reduction from an average high usual intake (203 mmol/day) to the recommended level (65 mmol/day) was small in study populations with normal blood pressure (BP) (â1.14/+0.01 mmHg) corresponding to a mean arterial pressure effect of only â0.38 mmHg . In hypertensive study populations the effect was (â5.71/â2.87 mmHg)corresponding to a mean arterial pressure effect of about â3.8 mmHg. In a subgroup analysis intending to eliminate the potential bias of a very short intervention duration (&lt; seven days) and very high sodium intake (&gt; 250 mmol/day), the decrease in BP in study populations with a normal BP (â1.38/â0.37 mmHg) and hypertension (â5.32/â2.76 mmHg) was also small. The effect of sodium reduction on hormones and on lipids showed increases in renin, aldosterone, noradrenalin, cholesterol and triglyceride in the primary analysis, as well as in the subgroup analysis, whereas the increase in adrenalin was small. The increase in cholesterol in the lowâsalt group seemed mainly to be due to an increase in lowâdensity lipoprotein (LDL). Sodium reduction had no effect on highâdensity lipoprotein (HDL). </p> <p>The analysis of black populations showed that the effect of sodium reduction in black people with normotension corresponded to the one found in black people with hypertension. This was in contrast to the analyses of white and Asian populations in whom the effect was smaller in those who were normotensive than in those who were hypertensive. However, compared with previous analyses (Graudal 1998; JÃ¼rgens 2003), the diverging results within the black populations and between the black and white populations are smaller. In a recent detailed analysis, we found that a significant fraction of the differences between the three racialÂ groups could be ascribed to differences in baseline BP, age, and amount of sodium reduction. Furthermore there was no difference in BP outcome between racialÂ groups investigated in the same study (<a href="./references#CD004022-bbs2-0277" title="GraudalN , JÃ¼rgensG . The blood pressure sensitivity to changes in sodium intake is similar in Asians, Blacks and Whites. An analysis of 92 randomized controlled trials. Front Physiology2015;6:157.">Graudal 2015b</a>) indicating that the differences found in the present metaâanalysis mainly may be due to confounders rather than racial differences. </p> <p>The funnel plots indicated that the effect of sodium reduction for on BP may have been a little overestimated for normotensives and a little underestimated for hypertensives. The funnel plot asymmetry for renin and aldosterone probably does not reflect publication bias, but rather that large sodium reductions to low levels of sodium intake mainly was performed in small studies. </p> </section> <section id="CD004022-sec-0066"> <h3 class="title" id="CD004022-sec-0066">Overall completeness and applicability of evidence</h3> <p>In the primary analysis, population samples from the whole BP distribution of the populations were included. In this analysis, the intake of sodium in the âhighâ sodium group was in the interval 100 mmol/day to 795 mmol/day in 217 comparisons (99%), and below 100 mmol/day in one comparison, the mean level being 203 mmol/day. The intake of sodium in the lowâsodium group was below 100 mmol/day in 178 comparisons (82%) and above 100 mmol/day in 39 comparisons, the mean level being 66 mmol/day. In the subgroup analysis, the intake of sodium in the âhighâ sodium group was in the interval 109 mmol/day to 248 mmol/day in 131 comparisons (100%), and below 100 mmol/day in zero comparisons, the mean level being 177 mmol/day. The intake of sodium in the lowâsodium group was below 100 mmol/day in 106 comparisons (81%) and above 100 mmol/day in 25 comparisons, the mean level being 68 mmol/day. Consequently, this metaâanalysis in general compares the effects of a dietary sodium intake, which is lower than usual and in accordance with the recommendations to reduce sodium below 100 mmol/day with a sodium intake, which is within the present worldâwide usual range of sodium intake, the level in the primary analysis being in the high end of the usual intake and the level in the subgroup analysis being close to the world mean of 159 mmol/day (<a href="http://Table 1" target="_blank">Table 1</a>). The mean and the range of the baseline 24âhour sodium excretion of the included populations before diet manipulation (159 mmol/24 hours (10 to 90 percentile: 123 to 194)) were almost identical with the usual range of sodium intake in the world's populations (McCarron 2013; Powles 2013). Thus, the present review shows the consequences of the recommendations of the health institutions, which is to reduce the usual sodium intake of the world's populations (90 mmol/day to 250 mmol/day) to a level below 87 mmol/day WHO 2012Â or below 100 mmol/day (IOM 2005, DGA 2015). </p> </section> <section id="CD004022-sec-0067"> <h3 class="title" id="CD004022-sec-0067">Quality of the evidence</h3> <p>Only randomised controlled trials were included and the basic grade of evidence was therefore considered to be high, although the grade of evidence was downgraded in some of the smaller analyses. In general, the description of the randomisation procedure was insufficient, introducing a bias which could exaggerate the effects, but many of the studies were published in a period where it was not customary to report such descriptions. This bias could not be explored in a meaningful way due to the lack of contrasts between the number of studies with low and high risk of these biases (<a href="http://Figure 1" target="_blank">Figure 1</a>). Almost all individual studies of participants with normal blood pressure (BP) show no significant effect of sodium reduction on BP, whereas a large number of studies in people with hypertension did show significant effect of sodium reduction on BP. Thus, there was a high grade of consistency between the outcomes of the individual studies and the outcomes of the metaâanalyses. Sensitivity analyses of studies lasting at least one week (the time of maximal efficacy) confirmed the primary analyses. Finally, the potential influence of commercial interests on the outcomes was negligible. </p> <p>In general the I<sup>2</sup> values indicated heterogeneity. There was significant clinical diversity in age, baseline BP and degree of sodium reduction across studies, which could explain a significant fraction of the heterogeneity. Our analysis of bias contrasts did not show obvious differences disclosing methodological diversity. If chance alone decides an effect of an intervention the distribution of effect sizes would be expected to be symmetrical around zero and the number of studies showing a positive effect would equal the number of studies showing a negative effect. Inspecting the forest plots, this is almost the case for the effect of sodium reduction on SBP and the case for DBP in normotensive white individuals indicating that most of the observed variation in the forest plots may be due to random variation. After elimination of the fourÂ most extreme positive and negative effects in each of these analyses the I<sup>2</sup> values generally fell to 40% or less indicating that heterogeneity might not be important (Higgins 2011). </p> <p>Concerning the hypertensive studies in white people, the I<sup>2</sup> values indicated moderate heterogeneity. Thus a downgrade of the GRADE assessment could be considered, but the statistical strength of the outcome is very strong and it is not likely that additional studies will change these outcomes, as we have previously shown in a cumulative metaâanalysis, which showed that the outcome was robust already after the inclusion of about 10 studies (Graudal 1998). In conclusion we have assessed the quality of the analyses in white people to be of high grade. In Asian normotensive participants the outcome was similar to the outcome in white people and the I<sup>2</sup> values for both SBP and DBP were small indicating that this outcome may be robust. Due to the few studies included we have downgraded the quality of this evidence to be moderate. The BP outcomes in the black study populations and Asian hypertensive study populations were all inconsistent as each of these groups could be separated in two subgroups with large and small effects, each having very low I<sup>2</sup> values, whereas the combined groups had very high I<sup>2</sup> values. Therefore, it is difficult to define a reliable effect, as the mean effect did not represent any of the two groups, indicating that further studies are needed to establish a robust result for these population groups. We have downgraded this evidence to be of low quality.<br/><br/>Concerning hormones there was consistency, as almost all studies showed the same trend, namely an increase in the hormone level, when sodium intake was reduced. Despite this the I<sup>2</sup> values showed substantial (noradrenalin and adrenalin) or considerable heterogeneity (renin and aldosterone). As the association between sodium intake and hormones may follow an exponential curve as proven for renin and aldosterone (Brunner 1972), the explanation for the large heterogeneity probably is that a reduction of sodium intake from a high level to a moderate level induces a factor 2 increase in hormones whereas a reduction of sodium intake from a moderate level to a low level induces a factor 5 increase in hormones, as we have previously shown (Graudal 1998). Due to narrow confidence intervals and consistency in the direction of the outcomes we have graded the quality of the hormone analyses to be high except for adrenalin, which was downgraded due to wide confidence limits and few studies.<br/>Concerning lipids all I<sup>2</sup> values were 0. Concerning cholesterol and triglyceride, there was also a high degree of consistency as most studies showed an increase, when sodium intake was reduced. Accordingly, we have graded these analyses to of high quality. The neutral result on HDL also seemed robust with confidence limits almost symmetrical around zero. In contrast, the neutral result on LDL seemed less robust with the lowest confidence limit close to zero, indicating that further studies might change the result to be significant. Accordingly, we downgraded the LDL result to be of moderate quality. </p> <p>The number of studies included in the BP analyses (n = 217) is substantial as is the number of participants (12232). This should allow robust conclusions. A weakness was that a large number of studies were not doubleâblind. However, concerning this source of bias, there were no obvious trends towards different effects in the lowârisk blinded groups compared with the highârisk open groups (<a href="http://Analysis 9.1" target="_blank">Analysis 9.1</a>; <a href="http://Analysis 9.2" target="_blank">Analysis 9.2</a>; <a href="http://Analysis 9.3" target="_blank">Analysis 9.3</a>; <a href="http://Analysis 9.4" target="_blank">Analysis 9.4</a>; <a href="http://Analysis 9.5" target="_blank">Analysis 9.5</a>; <a href="http://Analysis 9.6" target="_blank">Analysis 9.6</a>; <a href="http://Analysis 9.7" target="_blank">Analysis 9.7</a>; <a href="http://Analysis 9.8" target="_blank">Analysis 9.8</a>). </p> </section> <section id="CD004022-sec-0068"> <h3 class="title" id="CD004022-sec-0068">Potential biases in the review process</h3> <p>In the nineties journals did not generally demand protocols as a condition for publication and we did not publish a protocol before the 1998 version (Graudal 1998). Cochrane invited us to publish this finished paper as a Cochrane review. Consequently, there is no protocol. Registration of a protocol counteracts bias by revealing differences in methods or outcomes between the planned protocol and the published review. Thus, we cannot document the absence of such bias in our review. However, as multiple reviews (discussed below) with different inclusion criteria have found similar results, we assess that such potential bias have no impact on the present results. </p> <p>The present review is the largest of the many existing metaâanalyses on sodium reduction, and other metaâanalyses have not identified studies, which were not identified by our search. Our analysis is the largest partly because our selection criteria were less restrict. Therefore, a fraction of the included studies had an experimental character investigating a sodium intake far beyond the sodium intake in the general population for only four to six days, which may not be relevant for the general population on longâterm sodium reduction. The fact that the subgroup analysis, which eliminated the potential shortâterm intervention bias and very high sodium intake bias, showed similar results as the primary analysis, indicates that the inclusion of extreme studies had a minor impact on the mean of the outcome effects. Other metaâanalyses have extracted almost identical data in the individual studies indicating that our data extraction is unbiased. </p> <p>In total 24 of 651 people in the defined black populations were white people (3.7%) and 642 of 10308 in the defined white populations were black people (6.2%). We assess that these small contributions have no impact on the outcomes. </p> </section> <section id="CD004022-sec-0069"> <h3 class="title" id="CD004022-sec-0069">Agreements and disagreements with other studies or reviews</h3> <p>The scientific evidence behind the sodium reduction recommendations is a series of studies and metaâanalyses, which are biased by high baseline blood pressure, high age and overweight (<a href="./references#CD004022-bbs2-0273" title="GraudalN . Con: Reducing salt intake at the population level: is it really a public health priority?Nephrology Dialysis Transplantation2016;pii: gfw280. [Epub ahead of print]:1-6.">Graudal (3) 2016</a>). The most prominent of these studies (<a href="./references#CD004022-bbs2-0258" title="SacksF , SvetkeyLP , VollmerWM , AppelLJ , BrayGA , HarshaD , et al. Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (DASH) diet. New England Journal of Medicine2001;344:3-10.">DASH 2001</a>), was additionally biased by a control group diet, which was designed to contain only half of the normal amount of potassiumÂ (<a href="./references#CD004022-bbs2-0278" title="GraudalN, JÃ¼rgensG . Conflicting Evidence on Health Effects Associated with Salt Reduction Calls for a Redesign of the Salt Dietary Guidelines.. Prog Cardiovasc Dis2018;61:20-26.">Graudal and JÃ¼rgens 2018</a>). Despite these studies beingÂ irrelevant as evidence for pubic health recommendations, the Food and Drug Administration (FDA) has released draft proposed voluntary guideline to encourage companies to steadily reduce sodium in processed foods (<a href="./references#CD004022-bbs2-0266" title="FriedenTR . Sodium reduction-saving lives by putting choice into consumers hands. JAMA2016;316(6):579-80.">Frieden TR 2016</a>). The main argument for this guidelineÂ was a doseâresponse metaâregression analysis of mixed normotensive and hypertensive study populations, which was biased because it included mainly studies with high blood pressure and inappropriately forced the doseâresponse relationship through zero and thereby further doubled the postulated effect. In contrast, previous metaâanalyses of randomised controlled trials (RCTs) have shown similar results of sodium reduction on BP. In 1986, Grobbee and Hofman combined 13 studies of persons with normal and elevated BP in a metaâanalysis and found a significant hypotensive effect of reduced sodium intake on SBP of â3.6 mmHg and a nonâsignificant effect on DBP of â2.0 mmHg (Grobbee 1986). In 1991, a second metaâanalysis of 24 RCTs showed an effect of â4.0/â2.5 mmHg for persons with elevated BP and â1.0/â0.2 for persons with normal BP (Cutler 1991). This was verified in an update from 1997 (<a href="./references#CD004022-bbs2-0257" title="CutlerJA , FollmannD , AllenderPS . Randomized trials of sodium reduction: an overview. American Journal of Clinical Nutrition1997;65(2 Suppl):643S-651S.">Cutler 1997</a>). In 1996, a metaâanalysis of 53 RCTs showed an effect of â3.7/â0.9 mmHg in persons with elevated BP and â1.0/â0.1 in persons with normal BP (Midgley 1996). In an analysis of eight RCTs lasting for at least six months, the effect was â2.9/â2.1 mmHg for persons with elevated BP and â1.3/â 0.8 mmHg for persons with normal BP (<a href="./references#CD004022-bbs2-0262" title="EbrahimS , SmithGD . Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions. Journal of Public Health Medicine1998;20(4):441-8.">Ebrahim 1998</a>). These results were confirmed in an update (<a href="./references#CD004022-bbs2-0287" title="HooperL , BartlettC , SmithGD , EbrahimS . Systematic review of long term effects of advice to reduce dietary salt in adults. BMJ2002;325:628-35.">Hooper 2002</a>). All these similar results confirm that selection of RCTs based on magnitude of sodium difference or duration of the intervention does not significantly change the overall effect size estimate. These metaâanalyses indicate that major disagreements about this effect size no longer seem to exist. However, there is still significant disagreement regarding the relevance of the effect size and the relevance of potential side effects (<a href="./references#CD004022-bbs2-0310" title="TaubesG . The (political) science of salt. Science1998;281:898-907.">Taubes 1998</a>). </p> <p>The effect of sodium reduction on BP in hypertensive and normotensive study populations in the present review matches the effects found in most of these previous reviews, although the effect of sodium reduction on BP in normotensives is marginally lower than in the metaâanalysis, which supports the WHO recommendations (<a href="./references#CD004022-bbs2-0242" title="AburtoNJ , ZiolkovskaA , HooperL , ElliottP , CappuccioFP , MeerpohlJJ . Effect of lower sodium intake on health: systematic review and meta-analyses. BMJ2013;346:f1326.">Aburto 2013</a>). In hypertensive study populations, there was no differences between the WHO review and our review. In normotensive study populations, the difference was small, the BP effect in the WHO review being â1.38/â0.58 mmHg and in ours being â1.14/0.01 (â1.38/â0.37 in the subgroup analysis). This study differed from ours as it only included studies lasting at least four weeks. However, as duration has no impact on the BP effect (<a href="http://Table 2" target="_blank">Table 2</a>), a more reliable explanation for the difference between the WHO review and our review is that the study populations with normal BP in the WHO review generally have a high baseline BP in the upper 50% percentile of the population. </p> <p>According to WHO, the small effect in normotensive study populations is sufficient to recommend sodium reduction for the whole population, the assumption being that the association between BP and mortality is consistent. This, however, may not be the case. For instance, betaâblockers reduce BP in hypertensive individuals, but not mortality (<a href="./references#CD004022-bbs2-0319" title="WiysongeCS , BradleyHA , VolminkJ , MayosiBM , MbewuA , OpieLH . Beta-blockers for hypertension. Cochrane Database of Systematic Reviews2012, Issue 11. Art. No: CD002003. [DOI: 10.1002/14651858.CD002003.pub4]">Wiysonge 2012</a>), and a recent metaâanalysis of patients with diabetes showed that antihypertensive treatment reduces the risk of mortality and cardiovascular morbidity in diabetes patients with SBP higher than 140 mm Hg, but if SBP is less than140 mm Hg further treatment is associated with an increased risk of cardiovascular death, with no observed benefit (<a href="./references#CD004022-bbs2-0249" title="BrunstrÃ¶mM , CarlbergB . Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ2016;352:i717.">BrunstrÃ¶m 2016</a>). Such studies indicate that it is not possible to extend the general association of BP with mortality (Collins 1990) to the effect of a BPâreducing intervention on mortality. The reason for this inconsistency may be side effects of the intervention. However, while short duration has been suggested to underestimate the BP effect, it has concomitantly been suggested to overestimate possible adverse effects on hormones and lipids. This idea that the duration of the intervention tends to underestimate some physiological outcomes and overestimate others has not been documented, but still has been used to disregard side effects shown in studies lasting less than four weeks. Very few studies lasting more than four weeks have investigated side effects, and further more these studies do not reduce sodium to the recommended level, but to levels above 87 mmol/day, and therefore the side effects in these few studies may not be fully disclosed. In contrast, the present analysis shows that the adverse effects on hormones and lipids are significant, when the sodium intake is lowered from a high usual sodium intake to a level in accordance with the recommendations of the health institutions. In addition, we have just shown that sodium reduction results in an increase in heart rate of 2.4% (<a href="./references#CD004022-bbs2-0272" title="GraudalNA , Hubeck-GraudalT , JÃ¼rgensG . Reduced dietary sodium intake increases heart rate. a meta-analysis of 63 randomized controlled trials including 72 study populations. Front Physiology2016;7:111.">Graudal (2) 2016</a>). This may be an important side effect as resting heart rate is directly associated with mortality (<a href="./references#CD004022-bbs2-0286" title="HoJE , LarsonMG , GhorbaniA , ChengS , CoglianeseEE , VasanRS , et al. Long-term cardiovascular risks associated with an elevated heart rate: theFramingham Heart Study [2014 May 8;3(3):e000668. doi: 10.1161/JAHA.113.000668.]. Journal of the American Heart Association2014;3(3):e000668.">Ho 2014</a>; <a href="./references#CD004022-bbs2-0292" title="JensenMT , MarottJL , AllinKH , NordestgaardBG , JensenGB . Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: the Copenhagen City Heart Study. European Journal of Preventive Cardiology2012;19(1):102-8.">Jensen 2012</a>). The assumption that at least some of these effects may be persistent and not just temporary has been indicated in observational studies. Yanomamo Indians, who persistently ingest very small amounts of sodium, have a three times higher level of renin in the blood and a 10 times higher excretion of aldosterone in the urine than normal controls (<a href="./references#CD004022-bbs2-0304" title="OliverJW , CohenEL , NeelJV . Blood pressure, sodium intake, and sodium related hormones in the Yanomamo indians, a âno-saltâ culture. Circulation1975;52:146-51.">Oliver 1975</a>). Furthermore, renin and aldosterone rise slowly as long as the intake is above 100 mmol/day, but exponentially, when sodium intake is reduced to levels below 100 mmol/day (<a href="./references#CD004022-bbs2-0248" title="BrunnerHR , LaraghJH , BaerL , NewtonMA , GoodwinFT , KrakoffLR , et al. Essential hypertension: renin and aldosterone, heart attack and stroke. New England Journal of Medicine1972;286(9):441-9.">Brunner 1972</a>. Thus, the present metaâanalysis provides a possible explanation for the small effect of reduced sodium intake on blood pressure: compensatory activation of the reninâaldosterone system is proportional to the degree of sodium reduction. Furthermore, the increases in noradrenaline and adrenaline may contribute to this counterâregulation (<a href="./references#CD004022-bbs2-0315" title="WarrenSE , ViewegWVR , OâConnorDT . Sympathetic nervous system activity during sodium restriction in essential hypertension. Clinical Cardiology1980;3:348-51.">Warren 1980</a>) and contribute to an increase in heart rate. </p> <p>The very small effect of sodium reduction on BP in healthy individuals shown in the present review and other reviews including the WHO review, the risk of significant side effects shown in this review, and the possibility that an intervention to reduce BP may not reduce mortality (Wiysonge 2012), and even may increase mortality in some population groups with a normal BP (BrunstrÃ¶m 2016) indicate that the BPâeffect is not sufficient as a basis for recommendations in the general population, but should be verified in studies directly relating sodium intake with morbidity and mortality. Unfortunately, RCTs of the effect of sodium reduction below 100 mmol/day on mortality in healthy individuals do not exist (<a href="./references#CD004022-bbs2-0271" title="GraudalN . A radical sodium reduction policy is not supported by randomized controlled trials or observational studies: grading the evidence. American Journal of Hypertension2016;Jan 27 Epub ahead of print:1-6.">Graudal (1) 2016</a>). A recently updated metaâanalysis of eight RCTs with followâup data on morbidity and mortality found a nonâsignificant trend versus reduced cardiovascular (CV) morbidity, but could not demonstrate reduced allâcause mortality in the lowâsodium group (<a href="./references#CD004022-bbs2-0243" title="AdlerAJ , TaylorF , MartinN , GottliebS , TaylorRS , EbrahimS . Reduced dietary salt for the prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2014, Issue 12. Art. No: CD009217. [DOI: 10.1002/14651858.CD009217.pub3]">Adler 2014</a>). These trials were performed in overweight preâhypertensive or hypertensive individuals and the sodium reduction was not below 100 mmol/day, but down to 100 mmol/day. </p> <p>The sodiumâmortality relationship has also been estimated by means of 27 observational studies (<a href="./references#CD004022-bbs2-0245" title="AldermanMH . Reducing dietary sodium: the case for caution. JAMA2010;303(5):448-9.">Alderman 2010</a>; Mente 2016; <a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a>; <a href="./references#CD004022-bbs2-0306" title="PfisterR, MichelsG , SharpSJ , LubenR , WarehamNJ , KhawKT . Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. European Journal of Heart Failure2014;16:394-402.">Pfister 2014</a>), which directly asses the relationship between sodium intake in the individual and mortality. Most of these studies were evaluated in an IOM report (<a href="./references#CD004022-bbs2-0291" title="Institute of Medicine. Sodium Intake in Populations: Assessment of Evidence. Washington DC: National Academies Press, 2013.">IOM 2013</a>). This IOM report did not confirm the 100 mmol/day upper level for sodium intake, which was defined in a previous IOM report (IOM 2005), but concluded that âScience was insufficient and inadequate to establish whether reducing sodium intake below 2300 mg/d (100 mmol) either decreases or increases CVD risk in the general populationâ. A later metaâanalysis of these population studies found that a sodium intake below 114 mmol/day was associated with increased mortality, as was a sodium intake above 214 mmol/day (<a href="./references#CD004022-bbs2-0275" title="GraudalN , JÃ¼rgensG , BaslundB , AldermanMH . Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. American Journal of Hypertension2014;27:1129-37.">Graudal 2014</a>). Increased mortality with high sodium intake has also been shown in another metaâanalysis, which, however, did not investigate the effect of a low sodium intake (<a href="./references#CD004022-bbs2-0309" title="StrazzulloP , D'EliaL , KandalaNB , CappuccioFP . Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies. BMJ2009;339:b4567.">Strazzulo 2009</a>). This Uâshaped relation between sodium intake and mortality has been identified in several individual population studiesÂ (<a href="./references#CD004022-bbs2-0301" title="O'DonnellMJ , YusufS , MenteA , GaoP , MannJF , TeoK , et al. Urinary sodium and potassium excretion and risk of cardiovascular events. JAMA.2011;306:2229-38.">O'Donnell 2011</a>;Â <a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a>;Â Pfister 2014; <a href="./references#CD004022-bbs2-0312" title="ThomasMC , MoranJ , ForsblomC , HarjutsaloV , ThornL , AholaA , et al, FinnDiane Study Group. The association between dietary sodium intake, ESRD, and all-cause mortality inpatients with type 1 diabetes. Diabetes Care2011;34:861-6.">Thomas 2011</a>). The health institutions, however, generally do not accept this evidence from the observational studies (<a href="./references#CD004022-bbs2-0281" title="GunnJP , BarronJL , BowmanBA , MerrittRK , CogswellME , AngellSY , et al. Sodium reduction is a public health priority: reflections on the Institute of Medicineâs report, sodium intake in populations: assessment of evidence. American Journal of Hypertension2013;26(10):1178-80.">Gunn 2013</a>; <a href="./references#CD004022-bbs2-0316" title="WheltonPK , AppelLJ , SaccoRL , AndersonCA , AntmanEM , CampbellN , et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American HeartAssociation sodium reduction recommendations. Circulation2012;126(24):1280-9.">Whelton 2012</a>; WHO 2012). In a recent paper, which discusses methodological issues of observational studies, representatives of the American Heart Association state that the association of low sodium intake with increased mortality observed in observational studies may reflect that sick people have a low sodium intake (reverse causality: sick people with a high mortality have a low sodium intake, it is not the low sodium intake, which increases the mortality) (<a href="./references#CD004022-bbs2-0251" title="CobbLK , AndersonCA , ElliottP , HuFB , LiuK , NeatonJD , et al, American Heart Association Council on Lifestyle and Metabolic Health. Methodological issues in cohort studies that relate sodium intake to cardiovascular disease outcomes: a science advisory from the American Heart Association. Circulation2014;129(10):1173-86.">Cobb 2014</a>). This hypothesis is not directly supported by the observational studies, as the outcomes generally are adjusted for confounders such as cardiovascular and renal diseases and diabetes and show that the mortality associated with a low sodium intake is higher in healthy populations than in populations including sick individuals (<a href="./references#CD004022-bbs2-0275" title="GraudalN , JÃ¼rgensG , BaslundB , AldermanMH . Compared with usual sodium intake, low- and excessive-sodium diets are associated with increased mortality: a meta-analysis. American Journal of Hypertension2014;27:1129-37.">Graudal 2014</a>; <a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a>). <a href="#CD004022-tbl-0009">Table 4</a> shows a metaâanalysis of the risk of allâcause mortality in study populations within the usual sodium intake range versus a low sodium intake below 114 mmol/day (Graudal 2014) or below 130 mmol/day (<a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a>. The analysis is confined to include samples of individuals representative of the general populations and all individual study analyses are adjusted for multiple confounders such as cardiovascular disease, hypertension and diabetes. To further reduce the risk of reverse causality, the most healthy subgroup was included in the analysis, when results were given for subgroups, The possibility of reverse causality can never be completely excluded, but as a minimum there is no indication in population studies that sodium intake below 100 mmol/day has beneficial health effects in healthy individuals. In the NHANES I and III studies this was demonstrated by independent groups (Alderman 1998; Cohen 2008; He 1999; <a href="./references#CD004022-bbs2-0321" title="YangQ , LiuT , KuklinaEV , FlandersWD , HongY , GillespieC , et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine2011;171:1183-91.">Yang 2011</a>). Finally the recent analysis of NHANES V showed that sick individuals have exactly the same sodium intake as healthy individuals (<a href="./references#CD004022-bbs2-0252" title="CogswellME , LoriaCM , TerryAL , ZhaoL , WangCY , ChenTC , WrightJD , PfeifferCM , MerrittR , MoyCS , AppelLJ . Estimated 24-hour urinary sodium and potassium excretion in US adults. JAMA2018;319:1209-1220.">Cogswell 2018</a>) definitively confirming that the reverse causality hypothesis is unlikely (<a href="./references#CD004022-bbs2-0293" title="JÃ¼rgensG . Sodium Excretion in Population Subgroups. JAMA2018;320:719-720.">JÃ¼rgens 2018</a>). </p> <div class="table" id="CD004022-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Association of low sodium intake with mortality in prospective observational studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple adjustment*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exclusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N (LS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N (US)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR/OR (95% CI)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0244" title="AldermanMH , CohenH , MadhavanS . Dietary sodium intake andmortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet1998;351:781-5.">Alderman 1998</a> (NHANES I) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2837</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8509</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.80, to, 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0282" title="HeJ , OgdenLG , BazzanoLA , VupputuriS , LoriaC , WheltonPK . Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Archives of Internal Medicine2002;162:1619-24.">He 1999</a> (NHANES I) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overweight (BMI &gt; 27.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1699</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5098</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (0.88 to 1.09)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0314" title="TuomilehtoJ , JousilahtiP , RastenyteD , MoltchanovV , TanskanenA , PietinenP , et al. Urinary sodium excretion and cardiovascularmortality in Finland: a prospective study. Lancet2001;357:848-51.">Tuomilehto 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Males**</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>634</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.56 to 1.48)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0253" title="CohenHW , HailpernSM , FangJ , AldermanMH . Sodium intake and mortality in the NHANES II follow-up study. American Journal of Medicine2006;119(3):275.e7-14.">Cohen 2006</a> (NHANES II) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3711</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3443</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.67 to 0.91)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0269" title="GeleijnseJM , WittemanJC , StijnenT , KloosMW , HofmanA , GrobbeeDE . Sodium and potassium intake and risk of cardiovascular eventsand all-cause mortality: the Rotterdam Study. European Journal of Epidemiology2007;22(11):763-70.">Gelijnse 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CVD and HT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12 (0.86 to 1.46)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0254" title="CohenHW , HailpernSM , AldermanMH . Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). Jornal of General Internal Medicine2008;23(9):1297-1302.">Cohen 2008</a> (NHANES III) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2175</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4350</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.73 to 0.94)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0321" title="YangQ , LiuT , KuklinaEV , FlandersWD , HongY , GillespieC , et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine2011;171:1183-91.">Yang 2011</a> (NHANES III) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overweight (BMI &gt; 25)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3067</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6133</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.73 to 1.18)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0308" title="Stolarz-SkrzypekK , KuznetsovaT , ThijsL , TikhonoffV , SeidlerovÃ¡J , RichartT , et al. European Project on Genesin Hypertension (EPOGH) Investigators. Fatal and nonfatal outcomes,incidence of hypertension, and blood pressure changes in relation tourinary sodium excretion. JAMA2011;305:1777-85.">StolarzâSkrzypek 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1250</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1220</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.62 to 1.08)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0267" title="GardenerH , RundekT , WrightCB , ElkindMS , SaccoRL . Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke2012;43:1200-5.">Gardener 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1138</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>961</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.74 to 1.07)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0306" title="PfisterR, MichelsG , SharpSJ , LubenR , WarehamNJ , KhawKT . Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. European Journal of Heart Failure2014;16:394-402.">Pfister 2014</a> (Norfolk) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0â2 year events</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3070</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9249</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.82 to 1.02)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a> (PURE) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CVD, Cancer, DM,</p> <p>smokers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6162</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38643</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (0.54 to 0.71)]</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total (95% CI)#</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21369</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67078</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.76 to 0.93)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total (95% CI)##</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21123</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65450</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.76 to 0.98)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>Only studies, which were representative for the general population and which adjusted for confounders were included. </p> <p>If subgroup results were given, the results of the most healthy subgroup was used in the analysis to reduce </p> <p>the possibility of reverse causation</p> <p>#With primary NHANES analyses (<a href="./references#CD004022-bbs2-0244" title="AldermanMH , CohenH , MadhavanS . Dietary sodium intake andmortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet1998;351:781-5.">Alderman 1998</a>, <a href="./references#CD004022-bbs2-0254" title="CohenHW , HailpernSM , AldermanMH . Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). Jornal of General Internal Medicine2008;23(9):1297-1302.">Cohen 2008</a>) </p> <p>## With NHANES reâanalyses (<a href="./references#CD004022-bbs2-0282" title="HeJ , OgdenLG , BazzanoLA , VupputuriS , LoriaC , WheltonPK . Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Archives of Internal Medicine2002;162:1619-24.">He 1999</a>, <a href="./references#CD004022-bbs2-0321" title="YangQ , LiuT , KuklinaEV , FlandersWD , HongY , GillespieC , et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine2011;171:1183-91.">Yang 2011</a>) </p> <p>* Studies were generally adjusted for at least sex, age and CVD risk factors</p> <p>** In the male group a low salt intake group could not be identified, as the salt intake </p> <p>in the lowest salt intake quartile was up to 159 mmol.</p> <p><b>BMI:</b> body mass index; <b>CVD:</b> cardiovascular disease; <b>DM:</b> diabetes mellitus; <b>HT:</b> hypertension </p> </div> </div> <p>In addition to reverse causality, inaccurate measurements of sodium intake has been used to explain the association of low sodium intake with increased mortality (<a href="./references#CD004022-bbs2-0283" title="HeFJ , CampbellNRC , MaY , MacGregorGA , CogswellME , Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. International Journal of Epidemiology2018;0:1-12.">He 2018</a>), the claim being that more accurate multiple measurements would reverse the outcome. However, theÂ  individual sodium intake measurements are not inaccurate, they are imprecise. This is verified by some of the presented inconsistent data, which show that the outcome based on a single "inaccurate" estimate was almost identical with the outcome based on "accurate" multiple 24 hour measurements (<a href="./references#CD004022-bbs2-0283" title="HeFJ , CampbellNRC , MaY , MacGregorGA , CogswellME , Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. International Journal of Epidemiology2018;0:1-12.">He 2018</a>). Thus, although imprecise, the individual sodium intake data are sufficiently accurate to classify most of the participants in population studies in the right percentile (typically tertile, quartile or quintile) (Olde Engberink 2017; Graudal and Mente 2018). Furthemore the actual misclassifications are not systematic, but random (<a href="./references#CD004022-bbs2-0303" title="Olde EngberinkRHG , vanden HoekTC , vanNoordenneND , vanden BornBH , Peters-SengersH , Vogt L. Use of a single baseline versus multiyear 24-hour urine collection for estimation oflong-term sodium intake and associated cardiovascular and renal risk.. Circulation2017;136:917-926.">Olde Engberink 2017</a>; <a href="./references#CD004022-bbs2-0279" title='GraudalN , MenteA . Letter by Graudal and Mente Regarding Article, "Use of a Single Baseline Versus Multiyear 24-Hour Urine Collection for Estimation of Long-Term Sodium Intake and Associated Cardiovascular and Renal Riskâ. Circulation2018;137:1536-37.'>Graudal and Mente 2018</a>), which contributes to an underestimation of the outcome, but do not cause a change of the direction of the outcome (Olde Engberink 2017; <a href="./references#CD004022-bbs2-0263" title="FanL , TighiouartH , LeveyAS , BeckGJ , Sarnak MJ. Urinary sodium excretion and kidney failure in nondiabetic chronic kidney disease. Kidney Int2014;86:582-588.">Fan 2014</a>) </p> <p>The BP effect of reduced sodium intake has been related to age. Freedman and Petitti analysed data from Intersalt (<a href="./references#CD004022-bbs2-0288" title="Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ1988;297(6644):319-28.">Intersalt 1988</a>) and found the paradox that along with the significant association between increase in blood pressure with age and the salt excretion in urine, there was an inverse relationship between estimated BP and salt excretion in urine at age 20. Freedman stated that unless you preferred to conclude that salt should be eaten in high doses by youngsters and in reduced amounts by the elderly, the findings were probably due to uncontrolled confounding, not to variation in salt intake (<a href="./references#CD004022-bbs2-0265" title="FreedmanDA , PetittiDB . Salt and blood pressure: conventional wisdom reconsidered. Evaluation Review2001;25(3):267-87.">Freedman 2001</a>). Furthermore, it is now clear that the BP of different age cohorts in a crossâsectional study like Intersalt is not representative of each other, verified by a study showing that recent birth cohorts attained lower BP than did earlier birth cohorts in the period 1887 to 1994 (<a href="./references#CD004022-bbs2-0270" title="GoffDC , HowardG , RusselGB , LabartheDR . Birth cohort evidence of population influences on blood pressure in the United states 1887-1994. Annals of Epidemiology2001;11(4):271-9.">Goff 2001</a>). According to this study, based on data from more than 50,000 persons, it can be estimated that the median BP is about 15 mmHg lower in a 50âyear old person from a recent birth cohort compared with a 50âyear old from a birth cohort from the late 19th century. Consequently, there has been a dramatic fall in BP during the 20th century. In this context, the possible mean arterial pressure effect of sodium reduction of â0.7 mmHg in normotensive persons seems negligible. Finally, it has been difficult to maintain a significant sodium reduction in longerâterm studies, which should be taken into consideration, when recommending sodium reduction. One reason for this could be that the sodium intake is regulated by neuroâphysiological and hormonal mechanisms (<a href="./references#CD004022-bbs2-0268" title="GeerlingJC , LoewyAD . Central regulation of sodium appetite. Experimental Physiology2008;93(2):177-209.">Geerling 2008</a>), and therefore difficult to diverge from. </p> <p>The hypothetical consequences of the present findings are that people with normotension would have no benefit from sodium reduction, but may suffer from harms, because sodium reduction has a negligible effect on BP, but results in significant side effects. People with hypertension may benefit due to the effect on BP, but may also suffer from harms due to the side effects. This is exactly what was found in the most recent metaâanalysis of four population studies (133,000 individuals) in which the authors had access to individual participant data (<a href="./references#CD004022-bbs2-0298" title="MenteA , O'DonnellM , RangarajanS , DagenaisG , LearS , McQueenM , et al, PURE, EPIDREAM and ONTARGET/TRANSCEND Investigators. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet2016;388:465-75.">Mente 2016</a>). The conclusion was "Compared with moderate sodium intake, high sodium intake is associated with an increased risk of cardiovascular events and death in hypertensive populations (no association in normotensive population), while the association of low sodium intake with increased risk of cardiovascular events and death is observed in those with or without hypertension. These data suggest that lowering sodium intake is best targeted at populations with hypertension who consume high sodium diets", a conclusion, which matches perfectly with the results of the present metaâanalysis. </p> <p>A recent critical review has indicated that the choice and methods of evidence to support dietary guidelines were insufficientÂ (<a href="./references#CD004022-bbs2-0311" title="TeicholzN . The scientific report guiding the US dietary guidelines: is it scientific?BMJ2015;351:h4962.">Teicholz 2015</a>) Subsequently a National Academy of Medicine (NAM) report has expressed distrust in the process for the establishment of the dietary guidelines for Americans (DGA) (<a href="./references#CD004022-bbs2-0300" title="National Academy of Medicine. Redesigning the Process for Establishing the DietaryGuidelines for Americans. Washington: National Academy of Sciences., 2017.">NAM 2017</a>). The NAM report revealed that DGA was not based on a âa full body of evidence on a continuous basis over timeâ. The report concluded that âthe process to update the DGA should be comprehensively redesigned to allow it to adapt to changes in needs, evidence, and strategic prioritiesâ. Thus, fundamental problems in the process of the establishment of the DGA may in part explain the contrast between the public recommendations to lower sodium intake below 2300 mg and the evidence, which indicates that such a reduction is associated with only small effects on BP, a series of potentially harmful effects and increased mortality. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD004022-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-01" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD004022-fig-0001" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, SBP." data-id="CD004022-fig-0002" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, SBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, DBP." data-id="CD004022-fig-0003" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, outcome: 1.2 White participants, normotensive, DBP. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.2 Aldosterone (pg/mL)." data-id="CD004022-fig-0004" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.2 Aldosterone (pg/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.3 Noradrenaline (pg/mL)." data-id="CD004022-fig-0005" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Effect of salt reduction on hormones, outcome: 5.3 Noradrenaline (pg/mL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 6 Effect of salt reduction on lipids, outcome: 6.1 Cholesterol." data-id="CD004022-fig-0006" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 6 Effect of salt reduction on lipids, outcome: 6.1 Cholesterol.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-FIG-06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 1: White population, normotensive, SBP" data-id="CD004022-fig-0007" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 1: White population, normotensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 2: White population, normotensive, DBP" data-id="CD004022-fig-0008" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 2: White population, normotensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 3: White population, hypertensive, SBP" data-id="CD004022-fig-0009" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 3: White population, hypertensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 4: White population, hypertensive, DBP" data-id="CD004022-fig-0010" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, Outcome 4: White population, hypertensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 1: Black population, normotensive, SBP" data-id="CD004022-fig-0011" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 1: Black population, normotensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 2: Black population, normotensive, DBP" data-id="CD004022-fig-0012" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 2: Black population, normotensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 3: Black population, hypertensive, SBP" data-id="CD004022-fig-0013" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 3: Black population, hypertensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 4: Black population, hypertensive, DBP" data-id="CD004022-fig-0014" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants, Outcome 4: Black population, hypertensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 1: Asian population normotensive, SBP" data-id="CD004022-fig-0015" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 1: Asian population normotensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 2: Asian population, normotensive, DBP" data-id="CD004022-fig-0016" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 2: Asian population, normotensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 3: Asian population, hypertensive, SBP" data-id="CD004022-fig-0017" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 3: Asian population, hypertensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 4: Asian population, hypertensive, DBP" data-id="CD004022-fig-0018" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants, Outcome 4: Asian population, hypertensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 1: White population, normotensive, SBP" data-id="CD004022-fig-0019" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 1: White population, normotensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 2: White population, normotensive, DBP" data-id="CD004022-fig-0020" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 2: White population, normotensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 3: White population, hypertensive, SBP" data-id="CD004022-fig-0021" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 3: White population, hypertensive, SBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 4: White population, hypertensive, DBP" data-id="CD004022-fig-0022" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis, Outcome 4: White population, hypertensive, DBP </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Effect of salt reduction on hormones, Outcome 1: Renin (ng/mL/hour)" data-id="CD004022-fig-0023" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Effect of salt reduction on hormones, Outcome 1: Renin (ng/mL/hour)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Effect of salt reduction on hormones, Outcome 2: Aldosterone (pg/mL)" data-id="CD004022-fig-0024" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Effect of salt reduction on hormones, Outcome 2: Aldosterone (pg/mL)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Effect of salt reduction on hormones, Outcome 3: Noradrenaline (pg/mL)" data-id="CD004022-fig-0025" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Effect of salt reduction on hormones, Outcome 3: Noradrenaline (pg/mL)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Effect of salt reduction on hormones, Outcome 4: Adrenaline (pg/mL)" data-id="CD004022-fig-0026" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Effect of salt reduction on hormones, Outcome 4: Adrenaline (pg/mL)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 1: Renin (ng/mL/hour)" data-id="CD004022-fig-0027" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 1: Renin (ng/mL/hour) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-006.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 2: Aldosterone (pg/mL)" data-id="CD004022-fig-0028" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-006.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 2: Aldosterone (pg/mL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-006.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 3: Noradrenaline (pg/mL)" data-id="CD004022-fig-0029" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-006.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 3: Noradrenaline (pg/mL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-006.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 4: Adrenaline (pg/mL)" data-id="CD004022-fig-0030" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-006.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6: Effect of salt reduction on hormones, subgroup analysis, Outcome 4: Adrenaline (pg/mL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-006.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Effect of salt reduction on lipids, Outcome 1: Cholesterol (mg/dL)" data-id="CD004022-fig-0031" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Effect of salt reduction on lipids, Outcome 1: Cholesterol (mg/dL)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-007.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Effect of salt reduction on lipids, Outcome 2: Trigyceride (mg/dL)" data-id="CD004022-fig-0032" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-007.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7: Effect of salt reduction on lipids, Outcome 2: Trigyceride (mg/dL)</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-007.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Effect of salt reduction on lipids, Outcome 3: High density lipoprotein, HDL (mg/dL)" data-id="CD004022-fig-0033" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-007.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7: Effect of salt reduction on lipids, Outcome 3: High density lipoprotein, HDL (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-007.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Effect of salt reduction on lipids, Outcome 4: Low density lipoprotein, LDL (mg/dL)" data-id="CD004022-fig-0034" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-007.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7: Effect of salt reduction on lipids, Outcome 4: Low density lipoprotein, LDL (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-007.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 1: Cholesterol (mg/dL)" data-id="CD004022-fig-0035" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 1: Cholesterol (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-008.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 2: Trigyceride (mg/dL)" data-id="CD004022-fig-0036" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-008.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 2: Trigyceride (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-008.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 3: High density lipoprotein, HDL (mg/dL)" data-id="CD004022-fig-0037" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-008.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 3: High density lipoprotein, HDL (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-008.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 4: Low density lipoprotein, LDL (mg/dL)" data-id="CD004022-fig-0038" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-008.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8: Effect of salt reduction on lipids, subgroup analysis, Outcome 4: Low density lipoprotein, LDL (mg/dL) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-008.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 1: White population, normotensive, SBP blindingâhigh" data-id="CD004022-fig-0039" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 1: White population, normotensive, SBP blindingâhigh</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 2: White population, normotensive, SBP blindingâlow" data-id="CD004022-fig-0040" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 2: White population, normotensive, SBP blindingâlow</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 3: White population, normotensive, SBP outcomeâassesedâhigh" data-id="CD004022-fig-0041" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 3: White population, normotensive, SBP outcomeâassesedâhigh</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 4: White population, normotensive, SBP outcomeâassesedâlow" data-id="CD004022-fig-0042" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 4: White population, normotensive, SBP outcomeâassesedâlow</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 5: White population, hypertensive, SBP blindingâhigh" data-id="CD004022-fig-0043" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 5: White population, hypertensive, SBP blindingâhigh</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 6: White population, hypertensive, SBP blindingâlow" data-id="CD004022-fig-0044" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 6: White population, hypertensive, SBP blindingâlow</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 7: White population, hypertensive, SBP outcomeâassesedâhigh" data-id="CD004022-fig-0045" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 7: White population, hypertensive, SBP outcomeâassesedâhigh</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD004022-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/urn:x-wiley:14651858:media:CD004022:CD004022-CMP-009.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Bias analyses, Outcome 8: White population, hypertensive, SBP outcomeâassesedâlow" data-id="CD004022-fig-0046" src="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_t/tCD004022-CMP-009.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.8</div> <div class="figure-caption"> <p>Comparison 9: Bias analyses, Outcome 8: White population, hypertensive, SBP outcomeâassesedâlow</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/media/CDSR/CD004022/image_n/nCD004022-CMP-009.08.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD004022-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in white participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> White population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in Europe and North America </p> <p><b>Duration: Shortest duration 3 days in main analysis and 7 days in subgroupâanalysis.</b> </p> <p><b>Intervention:</b> Low sodium intake (Main analysis: Mean 64 mmol/24h. Subgroup analysis: Mean 65 mmol/24h) ) </p> <p><b>Comparison:</b> High sodium intake (Main analysis: Mean 204 mmol/24h. Subgroup analysis: Mean 192 mmol/24h)) </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean Difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.14 [â1.65 to â0.63]</p> <p><i>â1.38 [â1.87, â0.89]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5982<br/>(95) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0.01 [â0.37 to 0.39]</p> <p><i>â0.37 [â0.78, 0.04]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6276<br/>(96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â5.71 [â6.67 to â4.74]</p> <p><i>â5.32 [â6.36, â4.28]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3998<br/>(88) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>White population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.87 [â3.41 to â2.32]</p> <p><i>â2.76 [â3.38, â2.13]*</i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>4032<br/>(89) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>* Outcome of studies with duration of at least 7 days and high sodium intake of maximum 250 mmol </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in white participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004022-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in black participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Black population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in North America, UK and Africa </p> <p><b>Duration: Shortest duration 5 days .</b> </p> <p><b>Intervention:</b> Low sodium intake (Mean 66 mmol/24 h) </p> <p><b>Comparison:</b> High sodium intake (Mean 195 mmol/24h) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â4.02 (â7.37 to â0.68)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.01 (â4.37 to 0.35)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>253<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b><sup>low1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â6.64 (â9.00 to â4.27)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Black population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.91 (â4.52 to â1.30)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>398<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>1. Downgraded due to the wide confidence intervals, inconsistent outcomes and few studies </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in black participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004022-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in Asian participants</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Asian population with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units in Japan and China </p> <p><b>Duration: Shortest duration 6 days.</b> </p> <p><b>Intervention:</b> Low sodium intake (Mean 103 mmol/24h) </p> <p><b>Comparison:</b> High sodium intake (Mean 217 mmol/24h) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, normotensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.50 [â3.09, 0.10]</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, normotensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â1.06 [â2.53, 0.41]</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>950<br/>(5) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, hypertensive, SBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â7.75(â11.44 to â4.07)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Asian population, hypertensive, DBP</b> </p> <p>mmHg</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â2.68 (â4.21 to â1.15)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>254<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>low<sup>2</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>DBP:</b> diastolic blood pressure; <b>SBP:</b> systolic blood pressure </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>1. Downgraded due to few studies</p> <p>2. Downgraded due to wide confidence intervals, inconsistent outcomes and few studies</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for blood pressure in Asian participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004022-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for hormones</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Low sodium intake compared with high sodium intake for hormones</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units </p> <p><b>Intervention:</b> Low sodium intake </p> <p><b>Comparison:</b> High sodium intake </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Renin</b> </p> <p>ng/ml/hour</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1.56 [1.39 to 1.73]</p> <p><i><sub>N*: 1.83 [1.56 to 2.10]</sub> </i> </p> <p><i><sub>H*: 1.26 [1.04 to 1.49]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2904<br/>(91) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Aldosterone</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>102.4 [86.9 to 117.8]</p> <p><i><sub>N*: 123.8 [99.5 to 148.1</sub> </i><sub>]</sub> </p> <p><i><sub>H*: 67.4 [53.5 to 81.3]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2506<br/>(70) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Noradrenaline</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>62.3 [41.9 to 82.8]</p> <p><i><sub>N*: 61.5 [40.4 to 82.6]</sub> </i> </p> <p><i><sub>H*: 54.0 [1.8 to 106.2]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>878<br/>(38) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adrenaline</b> </p> <p>pg/mL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7.55 [0.85 to 14.26]</p> <p><i><sub>N*:9.1 [-1.2 to 19.4]</sub> </i> </p> <p><i><sub>H*:4.21 [-2.7 to 11.11]</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>331<br/>(16) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>moderate<sup>1</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. </p> <p><b>Very low quality:</b> We are very uncertain about the estimate. </p> <p><b>SMD:</b> standardised mean difference </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>N*: Study populations with mean SBP &lt; 140 mmHg and mean DBP &lt; 90 mmHg</p> <p>H*:Study populations with mean SBP &gt; 140 mmHg and/or mean DBP &gt; 90 mmHg</p> <p>1. Downgraded due to the wide confidence interval and few studies</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for hormones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD004022-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for lipids</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> Participants with normal or elevated blood pressure, but otherwise healthy </p> <p><b>Settings:</b> Hospital units </p> <p><b>Intervention:</b> Low sodium intake </p> <p><b>Comparison:</b> High sodium intake </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Mean difference<br/>(95% CI)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cholesterol</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5.19 [2.1 to 8.3]</p> <p><i><sub>N*:5.98 (2.0 to 10.0)</sub> </i> </p> <p><i><sub>H*:3.95 (-1.1, 9.0)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>917<br/>(28) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Trigyceride</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7.10 [3.1 to 11.1]</p> <p><i><sub>N*: 7.1 (2.9 to 11.4)</sub> </i> </p> <p><i><sub>H*: 7 (-3.7 to 17.8)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>712<br/>(20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Highâdensity lipoprotein (HDL)</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>â0.3 [â1.66, 1.05]</p> <p><i><sub>N*: 0 (-1.6 to 1.6)</sub> </i> </p> <p><i><sub>H*: -1 (-3.4 to 1.4)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>738<br/>(20) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ</p> <p><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lowâdensity lipoprotein (LDL)</b> </p> <p>mg/dL</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2.46 [â1.0 to 5.9]</p> <p><i><sub>N*: 2.6 (-1.5 to 6.7)</sub> </i> </p> <p><i><sub>H*: 2.2 (-4.0 to 8.4)</sub> </i> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>696<br/>(18) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/><b>high</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span>Â <span class="table-title">Summary of findings: Low sodium intake compared with high sodium intake for lipids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004022-tbl-0006"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Sodium intake in populations</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Recommended</p> <p>upper level*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, lower</p> <p>range*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, lower</p> <p>2.5%*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World,</p> <p>mean*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, Upper</p> <p>97.5%*</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World, upper</p> <p>range*</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0260" title="US Department of Health and Human Services, US Department of Agriculture. 2015-2020 DietaryGuidelines for Americans. 8th ed.Washington, DC: http://www.health.gov/DietaryGuidelines. Accessed December 16, 20152015.">DGA 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100<sup>1</sup> (2300)<sup>2</sup> </p> <p>(5800)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0318" title="WHO. Sodium Intake for Adults and Children. Geneva: WHO, 2012.">WHO 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87<sup>1</sup> (2000)<sup>2</sup> </p> <p>(5046)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0297" title="McCarronDA , KazaksAG , GeerlingJC , SternJS , GraudalNA . Normal range of human dietary sodium intake: a perspective based on 24-hour urinary sodium excretion worldwide. American Journal of Hypertension2013;26:1218-23.">McCarron 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90<sup>1</sup> (2070)<sup>2</sup> </p> <p>(5220)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109<sup>1</sup> (2500)<sup>2</sup> </p> <p>(6320)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>159<sup>1</sup> (3660)<sup>2</sup> </p> <p>(9220)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>209<sup>1</sup> (4810)<sup>2</sup> </p> <p>(12120)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248<sup>1</sup> (5700)<sup>2</sup> </p> <p>(14400)<sup>3</sup> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0307" title="PowlesJ , FahimiS , MichaR , KhatibzadehS , ShiP , EzzatiM , et al. Global, regional and national sodium intakesin 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide. BMJ Open2013;3:e003733.">Powles 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95<sup>1</sup> (2200)<sup>2</sup> </p> <p>(5510)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>172<sup>1</sup> (3950)<sup>2</sup> </p> <p>(10000)<sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>240<sup>1</sup> (5520)<sup>2</sup> </p> <p>(13920)<sup>3</sup> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>1mmol; 2mg sodium; 3 mg sodium chloride</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Sodium intake in populations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004022-tbl-0007"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Differences in BP effects of reduced sodium intake at different time points in longitudinal studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Comparison</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>References</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SBP diff. (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DBP diff. (95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 1 vs.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1070 Parker 1990 (H);1180 Palacios 2004 B;1183 Gates 2004 (H);1188 Swift 2005 (H)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.18 (â3.03 to 2.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.12 (â2.53 to 2.77)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 1 vs.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0064" title="ParkerM , PuddeyIB , BeilinLJ , VandongenR . Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension1990;16:398-406. ">1070 Parker 1990 (H)</a>;<a href="./references#CD004022-bbs2-0079" title="RuppertM , OverlackA , KollochR , KraftK , GÃ¶belB , StumpeKO . Neurohormonal and metabolic effects of severe and moderate salt restriction in non-obese normotensive adults. Hypertension1993;11:743-9. ">1088 Ruppert 1993</a>;<a href="./references#CD004022-bbs2-0109" title="SchorrU , DistlerA , SharmaAM . Effect of sodium chloride- and sodium bicarbonate-rich mineral water on blood pressure and metabolic parameters in elderly normotensive individuals: a randomized double-blind crossover trial. Journal of Hypertension1996;14:131-5. ">1128 Schorr 1996</a>;<a href="./references#CD004022-bbs2-0159" title="PalaciosC , WigertzK , MartinBR , JackmanL , PrattJH , PeacockM , et al. Sodium retention in black and white female adolescents in response to salt intake. Journal of Clinical Endocrinology &amp; Metabolism2004;89:1858-63. ">1180 Palacios 2004</a>;<a href="./references#CD004022-bbs2-0162" title="GatesPE , TanakaH , HiattWR , SealsDR . Dietary sodium restriction rapidly improves large elastic artery compliance inolder adults with systolic hypertension. Hypertension2004;44:35-41. ">1183 Gates 2004 (H)</a>;<a href="./references#CD004022-bbs2-0165" title="ForresterT , AdeyemoA , Soarres-WynterS , SargentL , BennettF , WilksR , et al. A randomized trial on sodium reduction in two developing countries. Journal of Human Hypertension2005;19:55-60. ">1186 Forrester 2005 N</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.50 (â3.20 to 2.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35 (â2.02 to 2.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.77</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 2 vs.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0011" title="MacGregorGA , MarkanduND , BestFE , ElderDM , CamJM , SagnellaGA , et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet1982;1(8268):351-5. ">1011 MacGregor 1982 (H)</a>;<a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0064" title="ParkerM , PuddeyIB , BeilinLJ , VandongenR . Two-way factorial study of alcohol and salt restriction in treated hypertensive men. Hypertension1990;16:398-406. ">1070 Parker 1990 (H)</a>;<a href="./references#CD004022-bbs2-0068" title="MascioliS , Grimm R Jr, LaunerC , et al. Sodium chloride raises blood pressure in normotensive subjects. The study of sodium and blood pressure. Hypertension1991;17(Suppl 1):I21-6. ">1075 Mascioli 1991</a>;<a href="./references#CD004022-bbs2-0076" title="CobiacL , NestelPJ , WingLMH , HowePRC . A low sodium diet supplemented with fish oil lowers blood pressure in the elderly. Journal of Hypertension1992;10:87-92. ">1082 Cobiac 1992</a> </p> <p><a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0086" title="FotherbyMD , PotterJF . Effects of moderate sodium restriction on clinic and twenty-four-hour ambulatory blood pressure in elderly hypertensive subjects. Journal of Hypertension1993;11:657-63. ">1100 Fotherby 1993 (H)</a>;<a href="./references#CD004022-bbs2-0074" title="HugginsRL , Di NicolantonioR , Morgan, TO. Preferred salt levels and salt taste acuity in human subjects after ingestion of untasted salt. Appetite1992;18:111-9. ">1080 Huggins 1992</a>;<a href="./references#CD004022-bbs2-0162" title="GatesPE , TanakaH , HiattWR , SealsDR . Dietary sodium restriction rapidly improves large elastic artery compliance inolder adults with systolic hypertension. Hypertension2004;44:35-41. ">1183 Gates 2004 (H)</a>;<a href="./references#CD004022-bbs2-0165" title="ForresterT , AdeyemoA , Soarres-WynterS , SargentL , BennettF , WilksR , et al. A randomized trial on sodium reduction in two developing countries. Journal of Human Hypertension2005;19:55-60. ">1186 Forrester 2005 N</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.10 (â1.88 to 1.68)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.20 (â1.12 to 0.72)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 2 vs.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0078" title="SciarroneSEG , BeilinLJ , RouseIL , RogersPB . A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. Journal of Hypertension1992;10:287-98. ">1085 Sciarrone 1992 (H)</a>;<a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.50 (â2.66 to 1.66)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.42 (â1.69 to 0.85)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Week 4 vs.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD004022-bbs2-0035" title="ChalmersJ , MorganT , DoyleA , DicksonB , HopperJ , MathewsJ , et al. Australian National Health and Medical Research Council dietary salt study in mild hypertension. Journal of Hypertension Supplement1986;4:S629-37. ">1039 ANHMRCDS 1986 (H)</a>;<a href="./references#CD004022-bbs2-0049" title="Australian National Health and Medical Research Council Dietary Salt Study Management Committee. Fall in blood pressure with modest reduction in dietary salt intake in mild hypertension. Lancet1989;1:399-402. ">1055 ANHMRCDS 1989 (H)</a>;<a href="./references#CD004022-bbs2-0078" title="SciarroneSEG , BeilinLJ , RouseIL , RogersPB . A factorial study of salt restriction and a low-fat/high-fibre diet in hypertensive subjects. Journal of Hypertension1992;10:287-98. ">1085 Sciarrone 1992 (H)</a>;<a href="./references#CD004022-bbs2-0084" title="NestelPJ , CliftonPM , NoakesM , McArthurR , HowePR . Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist:hip ratio. Journal of Hypertension1993;11:1387-94. ">1097 Nestel 1993</a>;<a href="./references#CD004022-bbs2-0181" title="NowsonCA , WattanapenpaiboonN , PachettA . Low-sodium Dietary Approaches to Stop Hypertension-type diet including lean red meat lowers blood pressure in postmenopausal women. Nutrition Research2009;29:8-18. ">1201 Nowson 2009 (H)</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.39 (â1.77 to 2.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>â0.22 (â1.50 to 1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Data from <a href="./references#CD004022-bbs2-0276" title="GraudalNA , Hubeck-GraudalT , JurgensG , McCarronDA . The significance of duration and dose of sodium reduction intervention in normotensive and hypertensive individuals. A meta-analysis. Advances in Nutrition2015;6(2):169-77.">Graudal 2015</a> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Differences in BP effects of reduced sodium intake at different time points in longitudinal studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004022-tbl-0008"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Acronyms used in table "Characteristics of included studies"</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adrenaline</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aldo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Aldosterone</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cholesterol</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CrossâOver</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>DBP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diastolic blood pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dur</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Duration</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High density lipoprotein</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hyp</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hypertension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>IT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intention to treat</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LDL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low density lipoprotein</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>LoFo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lost to followâup</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MAP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean arterial pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>M/F</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Male/Female</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Norm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Normotension</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NE</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Noradrenaline</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Op</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Open</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Parallel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>S</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Single blind</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SBP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systolic blood pressure</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium reduction</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TG</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Triglyceride</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>W/B/A:</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of white participants/ black participants/ Asian participants</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Acronyms used in table "Characteristics of included studies"</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD004022-tbl-0009"> <div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Association of low sodium intake with mortality in prospective observational studies</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multiple adjustment*</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Exclusion</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N (LS)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N (US)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR/OR (95% CI)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0244" title="AldermanMH , CohenH , MadhavanS . Dietary sodium intake andmortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet1998;351:781-5.">Alderman 1998</a> (NHANES I) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2837</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8509</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.80, to, 0.97)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0282" title="HeJ , OgdenLG , BazzanoLA , VupputuriS , LoriaC , WheltonPK . Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Archives of Internal Medicine2002;162:1619-24.">He 1999</a> (NHANES I) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overweight (BMI &gt; 27.3)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1699</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5098</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (0.88 to 1.09)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0314" title="TuomilehtoJ , JousilahtiP , RastenyteD , MoltchanovV , TanskanenA , PietinenP , et al. Urinary sodium excretion and cardiovascularmortality in Finland: a prospective study. Lancet2001;357:848-51.">Tuomilehto 2001</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Males**</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>634</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>311</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.91 (0.56 to 1.48)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0253" title="CohenHW , HailpernSM , FangJ , AldermanMH . Sodium intake and mortality in the NHANES II follow-up study. American Journal of Medicine2006;119(3):275.e7-14.">Cohen 2006</a> (NHANES II) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3711</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3443</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.78 (0.67 to 0.91)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0269" title="GeleijnseJM , WittemanJC , StijnenT , KloosMW , HofmanA , GrobbeeDE . Sodium and potassium intake and risk of cardiovascular eventsand all-cause mortality: the Rotterdam Study. European Journal of Epidemiology2007;22(11):763-70.">Gelijnse 2007</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CVD and HT</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>392</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.12 (0.86 to 1.46)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0254" title="CohenHW , HailpernSM , AldermanMH . Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). Jornal of General Internal Medicine2008;23(9):1297-1302.">Cohen 2008</a> (NHANES III) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2175</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4350</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.83 (0.73 to 0.94)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0321" title="YangQ , LiuT , KuklinaEV , FlandersWD , HongY , GillespieC , et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine2011;171:1183-91.">Yang 2011</a> (NHANES III) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Overweight (BMI &gt; 25)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3067</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6133</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.73 to 1.18)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0308" title="Stolarz-SkrzypekK , KuznetsovaT , ThijsL , TikhonoffV , SeidlerovÃ¡J , RichartT , et al. European Project on Genesin Hypertension (EPOGH) Investigators. Fatal and nonfatal outcomes,incidence of hypertension, and blood pressure changes in relation tourinary sodium excretion. JAMA2011;305:1777-85.">StolarzâSkrzypek 2011</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1250</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1220</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.62 to 1.08)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0267" title="GardenerH , RundekT , WrightCB , ElkindMS , SaccoRL . Dietary sodium and risk of stroke in the Northern Manhattan study. Stroke2012;43:1200-5.">Gardener 2012</a> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1138</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>961</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.74 to 1.07)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0306" title="PfisterR, MichelsG , SharpSJ , LubenR , WarehamNJ , KhawKT . Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study. European Journal of Heart Failure2014;16:394-402.">Pfister 2014</a> (Norfolk) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0â2 year events</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3070</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9249</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.82 to 1.02)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD004022-bbs2-0302" title="O'DonnellM , MenteA , RangarajanS , McQueenMJ , WangX , LiuL , et al, PURE Investigators. Urinary sodium and potassium excretion, mortality, and cardiovascular events. New England Journal of Medicine2014;371(7):612-23.">O'Donnell 2014</a> (PURE) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Yes</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CVD, Cancer, DM,</p> <p>smokers</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6162</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>38643</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (0.54 to 0.71)]</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total (95% CI)#</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21369</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>67078</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.76 to 0.93)</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Total (95% CI)##</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21123</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>65450</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.76 to 0.98)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p>Only studies, which were representative for the general population and which adjusted for confounders were included. </p> <p>If subgroup results were given, the results of the most healthy subgroup was used in the analysis to reduce </p> <p>the possibility of reverse causation</p> <p>#With primary NHANES analyses (<a href="./references#CD004022-bbs2-0244" title="AldermanMH , CohenH , MadhavanS . Dietary sodium intake andmortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet1998;351:781-5.">Alderman 1998</a>, <a href="./references#CD004022-bbs2-0254" title="CohenHW , HailpernSM , AldermanMH . Sodium intake and mortality follow-up in the Third National Health and Nutrition Examination Survey (NHANES III). Jornal of General Internal Medicine2008;23(9):1297-1302.">Cohen 2008</a>) </p> <p>## With NHANES reâanalyses (<a href="./references#CD004022-bbs2-0282" title="HeJ , OgdenLG , BazzanoLA , VupputuriS , LoriaC , WheltonPK . Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Archives of Internal Medicine2002;162:1619-24.">He 1999</a>, <a href="./references#CD004022-bbs2-0321" title="YangQ , LiuT , KuklinaEV , FlandersWD , HongY , GillespieC , et al. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine2011;171:1183-91.">Yang 2011</a>) </p> <p>* Studies were generally adjusted for at least sex, age and CVD risk factors</p> <p>** In the male group a low salt intake group could not be identified, as the salt intake </p> <p>in the lowest salt intake quartile was up to 159 mmol.</p> <p><b>BMI:</b> body mass index; <b>CVD:</b> cardiovascular disease; <b>DM:</b> diabetes mellitus; <b>HT:</b> hypertension </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Association of low sodium intake with mortality in prospective observational studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/full#CD004022-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 White population, normotensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9077</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.14 [â1.65, â0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 White population, normotensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [â0.37, 0.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 White population, hypertensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6116</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â5.71 [â6.67, â4.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 White population, hypertensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>6140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.87 [â3.41, â2.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Black population, normotensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â4.02 [â7.37, â0.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Black population, normotensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.01 [â4.37, 0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Black population, hypertensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â6.64 [â9.00, â4.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Black population, hypertensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>619</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.91 [â4.52, â1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in black participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Asian population normotensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.50 [â3.09, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Asian population, normotensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.06 [â2.53, 0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Asian population, hypertensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â7.75 [â11.44, â4.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Asian population, hypertensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>501</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.68 [â4.21, â1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in Asian participants</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 4.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 White population, normotensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7415</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.38 [â1.87, â0.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 White population, normotensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7727</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.37 [â0.78, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 White population, hypertensive, SBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â5.32 [â6.36, â4.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 White population, hypertensive, DBP <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â2.76 [â3.38, â2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>Â <span class="table-title">Effect of salt reduction on systolic blood pressure (SBP) and diastolic blood pressure (DBP) in white participants, subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 5.</span>Â <span class="table-title">Effect of salt reduction on hormones</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Renin (ng/mL/hour) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5650</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.66 [1.48, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.86 [1.61, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [1.16, 1.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Aldosterone (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5046</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>101.98 [86.50, 117.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2946</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>123.75 [99.50, 148.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>69.13 [53.12, 85.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Noradrenaline (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1790</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>62.33 [41.90, 82.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1236</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>61.51 [40.41, 82.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>554</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>54.02 [1.81, 106.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Adrenaline (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>662</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.55 [0.85, 14.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.07 [â1.21, 19.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>204</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.21 [â2.70, 11.11]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>Â <span class="table-title">Effect of salt reduction on hormones</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 6.</span>Â <span class="table-title">Effect of salt reduction on hormones, subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Renin (ng/mL/hour) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3600</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.29 [1.07, 1.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.2 Aldosterone (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>93.59 [73.22, 113.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.3 Noradrenaline (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>998</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>47.37 [28.07, 66.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.4 Adrenaline (pg/mL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>486</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.79 [0.31, 15.28]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span>Â <span class="table-title">Effect of salt reduction on hormones, subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 7.</span>Â <span class="table-title">Effect of salt reduction on lipids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Cholesterol (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.19 [2.07, 8.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1092</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.98 [1.99, 9.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>742</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.95 [â1.06, 8.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.2 Trigyceride (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.10 [3.14, 11.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.11 [2.85, 11.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>566</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.05 [â3.70, 17.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.3 High density lipoprotein, HDL (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1476</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.30 [â1.66, 1.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>958</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [â1.63, 1.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>518</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.00 [â3.43, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.4 Low density lipoprotein, LDL (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.46 [â0.97, 5.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.1 Normotensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>958</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.59 [â1.54, 6.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4.2 Hypertensive Subgroup</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>434</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.19 [â4.00, 8.38]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span>Â <span class="table-title">Effect of salt reduction on lipids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 8.</span>Â <span class="table-title">Effect of salt reduction on lipids, subgroup analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Cholesterol (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.31 [0.71, 7.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.2 Trigyceride (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>804</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.03 [2.01, 12.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.3 High density lipoprotein, HDL (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>982</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.68 [â2.17, 0.81]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.4 Low density lipoprotein, LDL (mg/dL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>898</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.74 [â1.18, 6.66]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span>Â <span class="table-title">Effect of salt reduction on lipids, subgroup analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD004022-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 9.</span>Â <span class="table-title">Bias analyses</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 White population, normotensive, SBP blindingâhigh <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7504</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.96 [â1.23, â0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.2 White population, normotensive, SBP blindingâlow <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.14 [â1.68, â0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.3 White population, normotensive, SBP outcomeâassesedâhigh <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â1.22 [â1.66, â0.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.4 White population, normotensive, SBP outcomeâassesedâlow <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5884</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â0.92 [â1.21, â0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.5 White population, hypertensive, SBP blindingâhigh <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3865</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â6.02 [â6.63, â5.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.6 White population, hypertensive, SBP blindingâlow <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1967</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â5.81 [â6.42, â5.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.7 White population, hypertensive, SBP outcomeâassesedâhigh <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2521</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â6.04 [â6.93, â5.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.8 White population, hypertensive, SBP outcomeâassesedâlow <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>â5.73 [â6.25, â5.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span>Â <span class="table-title">Bias analyses</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD004022.pub5/references#CD004022-tbl-0018">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD004022.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD004022-note-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD004022-note-0016">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="fa#CD004022-note-0013">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="fr#CD004022-note-0015">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="ko#CD004022-note-0011">íêµ­ì´</a> </li> <li class="section-language"> <a class="" href="ms#CD004022-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD004022-note-0014">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD004022-note-0010">ç¹é«ä¸­æ</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright Â© 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">Â Â Facebook</a> <a class="a2a_button_x share-button">Â Â X(Twitter)</a> <a class="a2a_button_whatsapp share-button">Â Â WhatsApp</a> <a class="a2a_dd share-button">Â Â View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004022\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004022\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004022\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD004022\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD004022\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Xsb6SJyC&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004022.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD004022.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">EspaÃ±ol</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">ÙØ§Ø±Ø³Û</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">FranÃ§ais</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">à¤¹à¤¿à¤¨à¥à¤¦à¥</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">æ¥æ¬èª</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">íêµ­ì´</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">PortuguÃªs</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Ð ÑÑÑÐºÐ¸Ð¹</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">RomÃ¢nÄ</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">à®¤à®®à®¿à®´à¯</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">ç¹é«ä¸­æ</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">ç®ä½ä¸­æ</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD004022.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD004022.pub5/full/es">EspaÃ±ol</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD004022.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727431833"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004022.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727431838"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD004022.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eabe29f53f573',t:'MTc0MDcyNzQzMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 